Retroviral DNA Integration

Chemical Reviews

Volumn 116, Issue 20, 2016, Pages 12730-12757

  Lesbats, Paul ^a   Engelman, Alan N ^b   Cherepanov, Peter ^a,c  

^a THE FRANCIS CRICK INSTITUTE   (United Kingdom)

^b HARVARD MEDICAL SCHOOL   (United States)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMOSOMES; DNA; GENE THERAPY; INTEGRATION; ONCOGENIC VIRUSES; VIRUSES;

CHROMOSOMAL DNAS; DRUG DEVELOPMENT; ENZYMATIC PROCESS; HOST CELLS; INTEGRASE PROTEIN; MOLECULAR MECHANISM; REACTION CHEMISTRY; RETROVIRAL VECTORS;

NUCLEIC ACIDS;

INTEGRASE; INTEGRASE INHIBITOR; VIRUS DNA;

CHEMISTRY; DNA REPAIR; DRUG DESIGN; ENZYMOLOGY; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS 1; PROTEIN CONFORMATION; VIRUS DNA CELL DNA INTERACTION;

DNA REPAIR; DNA, VIRAL; DRUG DESIGN; HIV INTEGRASE; HIV INTEGRASE INHIBITORS; HIV-1; PROTEIN CONFORMATION; VIRUS INTEGRATION;

EID: 84993661716     PISSN: 00092665     EISSN: 15206890     Source Type: Journal    
DOI: 10.1021/acs.chemrev.6b00125     Document Type: Review

References (399)

1. Rous, P. A Sarcoma of the Fowl Transmissible by an Agent Separable from the Tumor Cells J. Exp. Med. 1911, 13 (4) 397-411 10.1084/jem.13.4.397
2. Ellermann, V.; Bang, O. Experimentelle Leukämie Bei Hühnern Zentralbl. Bakteriol. Parasitenkd. Infectionskr. Hyg. Abt. Orig. 1908, 46, 595-609
3. Poiesz, B. J.; Ruscetti, F. W.; Gazdar, A. F.; Bunn, P. A.; Minna, J. D.; Gallo, R. C. Detection and Isolation of Type C Retrovirus Particles from Fresh and Cultured Lymphocytes of a Patient with Cutaneous T-Cell Lymphoma Proc. Natl. Acad. Sci. U. S. A. 1980, 77 (12) 7415-7419 10.1073/pnas.77.12.7415
4. Barre-Sinoussi, F.; Chermann, J. C.; Rey, F.; Nugeyre, M. T.; Chamaret, S.; Gruest, J.; Dauguet, C.; Axler-Blin, C.; Vezinet-Brun, F.; Rouzioux, C. et al. Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS) Science 1983, 220 (4599) 868-871 10.1126/science.6189183
5. Popovic, M.; Sarngadharan, M. G.; Read, E.; Gallo, R. C. Detection, Isolation, and Continuous Production of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and Pre-AIDS Science 1984, 224 (4648) 497-500 10.1126/science.6200935
6. Coffin, J. M. The Discovery of HTLV-1, the First Pathogenic Human Retrovirus Proc. Natl. Acad. Sci. U. S. A. 2015, 112 (51) 15525-15529 10.1073/pnas.1521629112
7. Temin, H. M. The Participation of DNA in Rous Sarcoma Virus Production Virology 1964, 23, 486-494 10.1016/0042-6822(64)90232-6
8. Donehower, L. A.; Varmus, H. E. A Mutant Murine Leukemia Virus with a Single Missense Codon in pol Is Defective in a Function Affecting Integration Proc. Natl. Acad. Sci. U. S. A. 1984, 81 (20) 6461-6465 10.1073/pnas.81.20.6461
9. Panganiban, A. T.; Temin, H. M. The Retrovirus pol Gene Encodes a Product Required for DNA Integration: Identification of a Retrovirus int Locus Proc. Natl. Acad. Sci. U. S. A. 1984, 81, 7885-7889 10.1073/pnas.81.24.7885
10. Schwartzberg, P.; Colicelli, J.; Goff, S. P. Construction and Analysis of Deletion Mutations in the pol Gene of Moloney Murine Leukemia Virus: A New Viral Function Required for Productive Infection Cell 1984, 37, 1043-1052 10.1016/0092-8674(84)90439-2
11. Quinn, T. P.; Grandgenett, D. P. Genetic Evidence That the Avian Retrovirus DNA Endonuclease Domain of pol Is Necessary for Viral Integration J. Virol. 1988, 62 (7) 2307-2312
12. Vande Woude, G. F.; Oskarsson, M.; Enquist, L. W.; Nomura, S.; Sullivan, M.; Fischinger, P. J. Cloning of Integrated Moloney Sarcoma Proviral DNA Sequences in Bacteriophage Lambda Proc. Natl. Acad. Sci. U. S. A. 1979, 76 (9) 4464-4468 10.1073/pnas.76.9.4464
13. Van Beveren, C.; Goddard, J. G.; Berns, A.; Verma, I. M. Structure of Moloney Murine Leukemia Viral DNA: Nucleotide Sequence of the 5′ Long Terminal Repeat and Adjacent Cellular Sequences Proc. Natl. Acad. Sci. U. S. A. 1980, 77 (6) 3307-3311 10.1073/pnas.77.6.3307
14. Shimotohno, K.; Mizutani, S.; Temin, H. M. Sequence of Retrovirus Provirus Resembles That of Bacterial Transposable Elements Nature 1980, 285 (5766) 550-554 10.1038/285550a0
15. Ju, G.; Skalka, A. M. Nucleotide Sequence Analysis of the Long Terminal Repeat (LTR) of Avian Retroviruses: Structural Similarities with Transposable Elements Cell 1980, 22 (2) 379-386 10.1016/0092-8674(80)90348-7
16. Bowerman, B.; Brown, P. O.; Bishop, J. M.; Varmus, H. E. A Nucleoprotein Complex Mediates the Integration of Retroviral DNA Genes Dev. 1989, 3 (4) 469-478 10.1101/gad.3.4.469
17. Wei, S. Q.; Mizuuchi, K.; Craigie, R. A Large Nucleoprotein Assembly at the Ends of the Viral DNA Mediates Retroviral DNA Integration EMBO J. 1997, 16 (24) 7511-7520 10.1093/emboj/16.24.7511
18. Farnet, C. M.; Haseltine, W. A. Determination of Viral Proteins Present in the Human Immunodeficiency Virus Type 1 Preintegration Complex J. Virol. 1991, 65 (4) 1910-1915
19. Bukrinsky, M. I.; Sharova, N.; McDonald, T. L.; Pushkarskaya, T.; Tarpley, W. G.; Stevenson, M. Association of Integrase, Matrix, and Reverse Transcriptase Antigens of Human Immunodeficiency Virus Type 1 with Viral Nucleic Acids Following Acute Infection Proc. Natl. Acad. Sci. U. S. A. 1993, 90 (13) 6125-6129 10.1073/pnas.90.13.6125
20. Heinzinger, N. K.; Bukinsky, M. I.; Haggerty, S. A.; Ragland, A. M.; Kewalramani, V.; Lee, M. A.; Gendelman, H. E.; Ratner, L.; Stevenson, M.; Emerman, M. The Vpr Protein of Human Immunodeficiency Virus Type 1 Influences Nuclear Localization of Viral Nucleic Acids in Nondividing Host Cells Proc. Natl. Acad. Sci. U. S. A. 1994, 91 (15) 7311-7315 10.1073/pnas.91.15.7311
21. Miller, M. D.; Farnet, C. M.; Bushman, F. D. Human Immunodeficiency Virus Type 1 Preintegration Complexes: Studies of Organization and Composition J. Virol. 1997, 71 (7) 5382-5390
22. Li, L.; Olvera, J. M.; Yoder, K. E.; Mitchell, R. S.; Butler, S. L.; Lieber, M.; Martin, S. L.; Bushman, F. D. Role of the Non-Homologous DNA End Joining Pathway in the Early Steps of Retroviral Infection EMBO J. 2001, 20 (12) 3272-3281 10.1093/emboj/20.12.3272
23. Lin, C. W.; Engelman, A. The Barrier-to-Autointegration Factor Is a Component of Functional Human Immunodeficiency Virus Type 1 Preintegration Complexes J. Virol. 2003, 77 (8) 5030-5036 10.1128/JVI.77.8.5030-5036.2003
24. Llano, M.; Vanegas, M.; Fregoso, O.; Saenz, D.; Chung, S.; Peretz, M.; Poeschla, E. M. LEDGF/p75 Determines Cellular Trafficking of Diverse Lentiviral but Not Murine Oncoretroviral Integrase Proteins and Is a Component of Functional Lentiviral Preintegration Complexes J. Virol. 2004, 78 (17) 9524-9537 10.1128/JVI.78.17.9524-9537.2004
25. Raghavendra, N. K.; Shkriabai, N.; Graham, R.; Hess, S.; Kvaratskhelia, M.; Wu, L. Identification of Host Proteins Associated with HIV-1 Preintegration Complexes Isolated from Infected CD4+ Cells Retrovirology 2010, 7, 66 10.1186/1742-4690-7-66
26. Schweitzer, C. J.; Jagadish, T.; Haverland, N.; Ciborowski, P.; Belshan, M. Proteomic Analysis of Early HIV-1 Nucleoprotein Complexes J. Proteome Res. 2013, 12 (2) 559-572 10.1021/pr300869h
27. Engelman, A. In HIV-1 Integrase: Mechanism and Inhibitor Design; Neamati, N., Ed.; John Wiley & Sons, Inc.: Hoboken, NJ, 2011; DOI: 10.1002/9781118015377.ch6.
28. Shin, C. G.; Taddeo, B.; Haseltine, W. A.; Farnet, C. M. Genetic Analysis of the Human Immunodeficiency Virus Type 1 Integrase Protein J. Virol. 1994, 68 (3) 1633-1642
29. Taddeo, B.; Haseltine, W. A.; Farnet, C. M. Integrase Mutants of Human Immunodeficiency Virus Type 1 with a Specific Defect in Integration J. Virol. 1994, 68 (12) 8401-8405
30. Engelman, A.; Englund, G.; Orenstein, J. M.; Martin, M. A.; Craigie, R. Multiple Effects of Mutations in Human Immunodeficiency Virus Type 1 Integrase on Viral Replication J. Virol. 1995, 69 (5) 2729-2736
31. Masuda, T.; Planelles, V.; Krogstad, P.; Chen, I. S. Genetic Analysis of Human Immunodeficiency Virus Type 1 Integrase and the U3 Att Site: Unusual Phenotype of Mutants in the Zinc Finger-Like Domain J. Virol. 1995, 69 (11) 6687-6696
32. Engelman, A. In Vivo Analysis of Retroviral Integrase Structure and Function Adv. Virus Res. 1999, 52, 411-426 10.1016/S0065-3527(08)60309-7
33. Leavitt, A. D.; Robles, G.; Alesandro, N.; Varmus, H. E. Human Immunodeficiency Virus Type 1 Integrase Mutants Retain in Vitro Integrase Activity yet Fail to Integrate Viral DNA Efficiently During Infection J. Virol. 1996, 70 (2) 721-728
34. Lu, R.; Limon, A.; Devroe, E.; Silver, P. A.; Cherepanov, P.; Engelman, A. Class II Integrase Mutants with Changes in Putative Nuclear Localization Signals Are Primarily Blocked at a Postnuclear Entry Step of Human Immunodeficiency Virus Type 1 Replication J. Virol. 2004, 78 (23) 12735-12746 10.1128/JVI.78.23.12735-12746.2004
35. Lu, R.; Vandegraaff, N.; Cherepanov, P.; Engelman, A. Lys-34, Dispensable for Integrase Catalysis, Is Required for Preintegration Complex Function and Human Immunodeficiency Virus Type 1 Replication J. Virol. 2005, 79 (19) 12584-12591 10.1128/JVI.79.19.12584-12591.2005
36. Rahman, S.; Lu, R.; Vandegraaff, N.; Cherepanov, P.; Engelman, A. Structure-Based Mutagenesis of the Integrase-LEDGF/p75 Interface Uncouples a Strict Correlation between in Vitro Protein Binding and HIV-1 Fitness Virology 2007, 357, 79-90 10.1016/j.virol.2006.08.011
37. Ansari-Lari, M. A.; Donehower, L. A.; Gibbs, R. A. Analysis of Human Immunodeficiency Virus Type 1 Integrase Mutants Virology 1995, 211 (1) 332-335 10.1006/viro.1995.1412
38. Nakamura, T.; Masuda, T.; Goto, T.; Sano, K.; Nakai, M.; Harada, S. Lack of Infectivity of HIV-1 Integrase Zinc Finger-Like Domain Mutant with Morphologically Normal Maturation Biochem. Biophys. Res. Commun. 1997, 239 (3) 715-722 10.1006/bbrc.1997.7541
39. Lu, R.; Ghory, H. Z.; Engelman, A. Genetic Analyses of Conserved Residues in the Carboxyl-Terminal Domain of Human Immunodeficiency Virus Type 1 Integrase J. Virol. 2005, 79 (16) 10356-10368 10.1128/JVI.79.16.10356-10368.2005
40. Ikeda, T.; Nishitsuji, H.; Zhou, X.; Nara, N.; Ohashi, T.; Kannagi, M.; Masuda, T. Evaluation of the Functional Involvement of Human Immunodeficiency Virus Type 1 Integrase in Nuclear Import of Viral cDNA During Acute Infection J. Virol. 2004, 78 (21) 11563-11573 10.1128/JVI.78.21.11563-11573.2004
41. Ao, Z.; Fowke, K. R.; Cohen, E. A.; Yao, X. Contribution of the C-Terminal Tri-Lysine Regions of Human Immunodeficiency Virus Type 1 Integrase for Efficient Reverse Transcription and Viral DNA Nuclear Import Retrovirology 2005, 2, 62 10.1186/1742-4690-2-62
42. Hehl, E. A.; Joshi, P.; Kalpana, G. V.; Prasad, V. R. Interaction between Human Immunodeficiency Virus Type 1 Reverse Transcriptase and Integrase Proteins J. Virol. 2004, 78 (10) 5056-5067 10.1128/JVI.78.10.5056-5067.2004
43. Tekeste, S. S.; Wilkinson, T. A.; Weiner, E. M.; Xu, X.; Miller, J. T.; Le Grice, S. F.; Clubb, R. T.; Chow, S. A. Interaction between Reverse Transcriptase and Integrase Is Required for Reverse Transcription During HIV-1 Replication J. Virol. 2015, 89 (23) 12058-12069 10.1128/JVI.01471-15
44. Wu, X.; Liu, H.; Xiao, H.; Conway, J. A.; Hehl, E.; Kalpana, G. V.; Prasad, V.; Kappes, J. C. Human Immunodeficiency Virus Type 1 Integrase Protein Promotes Reverse Transcription through Specific Interactions with the Nucleoprotein Reverse Transcription Complex J. Virol. 1999, 73 (3) 2126-2135
45. Balakrishnan, M.; Yant, S. R.; Tsai, L.; O'Sullivan, C.; Bam, R. A.; Tsai, A.; Niedziela-Majka, A.; Stray, K. M.; Sakowicz, R.; Cihlar, T. Non-Catalytic Site HIV-1 Integrase Inhibitors Disrupt Core Maturation and Induce a Reverse Transcription Block in Target Cells PLoS One 2013, 8 (9) e74163 10.1371/journal.pone.0074163
46. Jurado, K. A.; Wang, H.; Slaughter, A.; Feng, L.; Kessl, J. J.; Koh, Y.; Wang, W.; Ballandras-Colas, A.; Patel, P. A.; Fuchs, J. R. et al. Allosteric Integrase Inhibitor Potency Is Determined through the Inhibition of HIV-1 Particle Maturation Proc. Natl. Acad. Sci. U. S. A. 2013, 110 (21) 8690-8695 10.1073/pnas.1300703110
47. Fontana, J.; Jurado, K. A.; Cheng, N.; Ly, N. L.; Fuchs, J. R.; Gorelick, R. J.; Engelman, A. N.; Steven, A. C. Distribution and Redistribution of HIV-1 Nucleocapsid Protein in Immature, Mature, and Integrase-Inhibited Virions: A Role for Integrase in Maturation J. Virol. 2015, 89 (19) 9765-9780 10.1128/JVI.01522-15
48. Gallay, P.; Hope, T.; Chin, D.; Trono, D. HIV-1 Infection of Nondividing Cells through the Recognition of Integrase by the Importin/Karyopherin Pathway Proc. Natl. Acad. Sci. U. S. A. 1997, 94, 9825-9830 10.1073/pnas.94.18.9825
49. Bouyac-Bertoia, M.; Dvorin, J. D.; Fouchier, R. A.; Jenkins, Y.; Meyer, B. E.; Wu, L. I.; Emerman, M.; Malim, M. H. HIV-1 Infection Requires a Functional Integrase NLS Mol. Cell 2001, 7, 1025-1035 10.1016/S1097-2765(01)00240-4
50. Dvorin, J. D.; Bell, P.; Maul, G. G.; Yamashita, M.; Emerman, M.; Malim, M. H. Reassessment of the Roles of Integrase and the Central DNA Flap in Human Immunodeficiency Virus Type 1 Nuclear Import J. Virol. 2002, 76 (23) 12087-12096 10.1128/JVI.76.23.12087-12096.2002
51. Limón, A.; Devroe, E.; Lu, R.; Ghory, H. Z.; Silver, P. A.; Engelman, A. Nuclear Localization of Human Immunodeficiency Virus Type 1 Preintegration Complexes (PICs): V165A and R166A Are Pleiotropic Integrase Mutants Primarily Defective for Integration, Not PIC Nuclear Import J. Virol. 2002, 76 (21) 10598-10607 10.1128/JVI.76.21.10598-10607.2002
52. Christ, F.; Thys, W.; De Rijck, J.; Gijsbers, R.; Albanese, A.; Arosio, D.; Emiliani, S.; Rain, J. C.; Benarous, R.; Cereseto, A. et al. Transportin-SR2 Imports HIV into the Nucleus Curr. Biol. 2008, 18, 1192-1202 10.1016/j.cub.2008.07.079
53. Krishnan, L.; Matreyek, K. A.; Oztop, I.; Lee, K.; Tipper, C. H.; Li, X.; Dar, M. J.; KewalRamani, V. N.; Engelman, A. The Requirement for Cellular Transportin 3 (TNPO3 or TRN-SR2) During Infection Maps to Human Immunodeficiency Virus Type 1 Capsid and Not Integrase J. Virol. 2010, 84 (1) 397-406 10.1128/JVI.01899-09
54. De Houwer, S.; Demeulemeester, J.; Thys, W.; Rocha, S.; Dirix, L.; Gijsbers, R.; Christ, F.; Debyser, Z. The HIV-1 Integrase Mutant R263A/K264A Is 2-Fold Defective for TRN-SR2 Binding and Viral Nuclear Import J. Biol. Chem. 2014, 289 (36) 25351-25361 10.1074/jbc.M113.533281
55. Brown, P. O.; Bowerman, B.; Varmus, H. E.; Bishop, J. M. Correct Integration of Retroviral DNA in Vitro Cell 1987, 49 (3) 347-356 10.1016/0092-8674(87)90287-X
56. Farnet, C. M.; Haseltine, W. A. Integration of Human Immunodeficiency Virus Type 1 DNA in Vitro Proc. Natl. Acad. Sci. U. S. A. 1990, 87 (11) 4164-4168 10.1073/pnas.87.11.4164
57. Ellison, V.; Abrams, H.; Roe, T.; Lifson, J.; Brown, P. Human Immunodeficiency Virus Integration in a Cell-Free System J. Virol. 1990, 64 (6) 2711-2715
58. Engelman, A.; Oztop, I.; Vandegraaff, N.; Raghavendra, N. K. Quantitative Analysis of HIV-1 Preintegration Complexes Methods 2009, 47, 283-290 10.1016/j.ymeth.2009.02.005
59. Gianni, A. M.; Smotkin, D.; Weinberg, R. A. Murine Leukemia Virus: Detection of Unintegrated Double-Stranded DNA Forms of the Provirus Proc. Natl. Acad. Sci. U. S. A. 1975, 72 (2) 447-451 10.1073/pnas.72.2.447
60. Shank, P. R.; Hughes, S. H.; Kung, H. J.; Majors, J. E.; Quintrell, N.; Guntaka, R. V.; Bishop, J. M.; Varmus, H. E. Mapping Unintegrated Avian Sarcoma Virus DNA: Termini of Linear DNA Bear 300 Nucleotides Present Once or Twice in Two Species of Circular DNA Cell 1978, 15 (4) 1383-1395 10.1016/0092-8674(78)90063-6
61. Shank, P. R.; Varmus, H. E. Virus-Specific DNA in the Cytoplasm of Avian Sarcoma Virus-Infected Cells Is a Precursor to Covalently Closed Circular Viral DNA in the Nucleus J. Virol. 1978, 25 (1) 104
62. Yoshimura, F. K.; Weinberg, R. A. Restriction Endonuclease Cleavage of Linear and Closed Circular Murine Leukemia Viral DNAs: Discovery of a Smaller Circular Form Cell 1979, 16 (2) 323-332 10.1016/0092-8674(79)90009-6
63. Shoemaker, C.; Goff, S.; Gilboa, E.; Paskind, M.; Mitra, S. W.; Baltimore, D. Structure of a Cloned Circular Moloney Murine Leukemia Virus DNA Molecule Containing an Inverted Segment: Implications for Retrovirus Integration Proc. Natl. Acad. Sci. U. S. A. 1980, 77 (7) 3932-3936 10.1073/pnas.77.7.3932
64. Pang, S.; Koyanagi, Y.; Miles, S.; Wiley, C.; Vinters, H. V.; Chen, I. S. High Levels of Unintegrated HIV-1 DNA in Brain Tissue of AIDS Dementia Patients Nature 1990, 343 (6253) 85-89 10.1038/343085a0
65. Mizuuchi, K.; Nash, H. A. Restriction Assay for Integrative Recombination of Bacteriophage Lambda DNA in Vitro: Requirement for Closed Circular DNA Substrate Proc. Natl. Acad. Sci. U. S. A. 1976, 73, 3524-3528 10.1073/pnas.73.10.3524
66. Panganiban, A. T.; Temin, H. M. Circles with Two Tandem LTRS Are Precursors to Integrated Retrovirus DNA Cell 1984, 36, 673-679 10.1016/0092-8674(84)90347-7
67. Fujiwara, T.; Mizuuchi, K. Retroviral DNA Integration: Structure of an Integration Intermediate Cell 1988, 54 (4) 497-504 10.1016/0092-8674(88)90071-2
68. Brown, P. O.; Bowerman, B.; Varmus, H. E.; Bishop, J. M. Retroviral Integration: Structure of the Initial Covalent Product and Its Precursor, and a Role for the Viral in Protein Proc. Natl. Acad. Sci. U. S. A. 1989, 86 (8) 2525-2529 10.1073/pnas.86.8.2525
69. Roth, M. J.; Schwartzberg, P. L.; Goff, S. P. Structure of the Termini of DNA Intermediates in the Integration of Retroviral DNA: Dependence on in Function and Terminal DNA Sequence Cell 1989, 58 (1) 47-54 10.1016/0092-8674(89)90401-7
70. Fujiwara, T.; Craigie, R. Integration of Mini-Retroviral DNA: A Cell-Free Reaction for Biochemical Analysis of Retroviral Integration Proc. Natl. Acad. Sci. U. S. A. 1989, 86 (9) 3065-3069 10.1073/pnas.86.9.3065
71. Katzman, M.; Katz, R. A.; Skalka, A. M.; Leis, J. The Avian Retroviral Integration Protein Cleaves the Terminal Sequences of Linear Viral DNA at the in Vivo Sites of Integration J. Virol. 1989, 63 (12) 5319-5327
72. Vora, A. C.; Fitzgerald, M. L.; Grandgenett, D. P. Removal of 3′-OH-Terminal Nucleotides from Blunt-Ended Long Terminal Repeat Termini by the Avian Retrovirus Integration Protein J. Virol. 1990, 64 (11) 5656-5659
73. Katz, R. A.; Merkel, G.; Kulkosky, J.; Leis, J.; Skalka, A. M. The Avian Retroviral IN Protein Is Both Necessary and Sufficient for Integrative Recombination in Vitro Cell 1990, 63 (1) 87-95 10.1016/0092-8674(90)90290-U
74. Craigie, R.; Fujiwara, T.; Bushman, F. The IN Protein of Moloney Murine Leukemia Virus Processes the Viral DNA Ends and Accomplishes Their Integration in Vitro Cell 1990, 62, 829-837 10.1016/0092-8674(90)90126-Y
75. Bushman, F. D.; Fujiwara, T.; Craigie, R. Retroviral DNA Integration Directed by HIV Integration Protein in Vitro Science 1990, 249, 1555-1558 10.1126/science.2171144
76. Bushman, F. D.; Craigie, R. Activities of Human Immunodeficiency Virus (HIV) Integration Protein in Vitro: Specific Cleavage and Integration of HIV DNA Proc. Natl. Acad. Sci. U. S. A. 1991, 88, 1339-1343 10.1073/pnas.88.4.1339
77. Sherman, P. A.; Fyfe, J. A. Human Immunodeficiency Virus Integration Protein Expressed in Escherichia Coli Possesses Selective DNA Cleaving Activity Proc. Natl. Acad. Sci. U. S. A. 1990, 87, 5119-5123 10.1073/pnas.87.13.5119
78. Dyda, F.; Chandler, M.; Hickman, A. B. The Emerging Diversity of Transpososome Architectures Q. Rev. Biophys. 2012, 45 (4) 493-521 10.1017/S0033583512000145
79. Mizuuchi, K.; Adzuma, K. Inversion of the Phosphate Chirality at the Target Site of Mu DNA Strand Transfer: Evidence for a One-Step Transesterification Mechanism Cell 1991, 66 (1) 129-140 10.1016/0092-8674(91)90145-O
80. Engelman, A.; Mizuuchi, K.; Craigie, R. HIV-1 DNA Integration: Mechanism of Viral DNA Cleavage and DNA Strand Transfer Cell 1991, 67 (6) 1211-1221 10.1016/0092-8674(91)90297-C
81. Kennedy, A. K.; Haniford, D. B.; Mizuuchi, K. Single Active Site Catalysis of the Successive Phosphoryl Transfer Steps by DNA Transposases: Insights from Phosphorothioate Stereoselectivity Cell 2000, 101 (3) 295-305 10.1016/S0092-8674(00)80839-9
82. Reznikoff, W. S. Tn5 as a Model for Understanding DNA Transposition Mol. Microbiol. 2003, 47 (5) 1199-1206 10.1046/j.1365-2958.2003.03382.x
83. Haniford, D. B. Transpososome Dynamics and Regulation in Tn10 Transposition Crit. Rev. Biochem. Mol. Biol. 2006, 41 (6) 407-424 10.1080/10409230600987415
84. Chen, H.; Wei, S.-Q.; Engelman, A. Multiple Integrase Functions Are Required to Form the Native Structure of the Human Immunodeficiency Virus Type I Intasome J. Biol. Chem. 1999, 274 (24) 17358-17364 10.1074/jbc.274.24.17358
85. Hare, S.; Gupta, S. S.; Valkov, E.; Engelman, A.; Cherepanov, P. Retroviral Intasome Assembly and Inhibition of DNA Strand Transfer Nature 2010, 464 (7286) 232-236 10.1038/nature08784
86. Shoemaker, C.; Hoffman, J.; Goff, S. P.; Baltimore, D. Intramolecular Integration within Moloney Murine Leukemia Virus DNA J. Virol. 1981, 40, 164-172
87. Li, Y.; Kappes, J. C.; Conway, J. A.; Price, R. W.; Shaw, G. M.; Hahn, B. H. Molecular Characterization of Human Immunodeficiency Virus Type 1 Cloned Directly from Uncultured Human Brain Tissue: Identification of Replication-Competent and -Defective Viral Genomes J. Virol. 1991, 65, 3973-3985
88. Tipper, C.; Sodroski, J. Enhanced Autointegration in Hyperstable Simian Immunodeficiency Virus Capsid Mutants Blocked after Reverse Transcription J. Virol. 2013, 87 (7) 3628-3639 10.1128/JVI.03239-12
89. Zheng, R.; Ghirlando, R.; Lee, M. S.; Mizuuchi, K.; Krause, M.; Craigie, R. Barrier-to-Autointegration Factor (BAF) Bridges DNA in a Discrete, Higher-Order Nucleoprotein Complex Proc. Natl. Acad. Sci. U. S. A. 2000, 97 (16) 8997-9002 10.1073/pnas.150240197
90. Skoko, D.; Li, M.; Huang, Y.; Mizuuchi, M.; Cai, M.; Bradley, C. M.; Pease, P. J.; Xiao, B.; Marko, J. F.; Craigie, R. et al. Barrier-to-Autointegration Factor (BAF) Condenses DNA by Looping Proc. Natl. Acad. Sci. U. S. A. 2009, 106 (39) 16610-16615 10.1073/pnas.0909077106
91. Lee, M. S.; Craigie, R. A Previously Unidentified Host Protein Protects Retroviral DNA from Autointegration Proc. Natl. Acad. Sci. U. S. A. 1998, 95 (4) 1528-1533 10.1073/pnas.95.4.1528
92. Yan, N.; Cherepanov, P.; Daigle, J. E.; Engelman, A.; Lieberman, J. The SET Complex Acts as a Barrier to Autointegration of HIV-1 PLoS Pathog. 2009, 5, e1000327 10.1371/journal.ppat.1000327
93. Pahl, A.; Flügel, R. M. Endonucleolytic Cleavages and DNA-Joining Activities of the Integration Protein of Human Foamy Virus J. Virol. 1993, 67, 5426-5434
94. Sinha, S.; Pursley, M. H.; Grandgenett, D. P. Efficient Concerted Integration by Recombinant Human Immunodeficiency Virus Type 1 Integrase without Cellular or Viral Cofactors J. Virol. 2002, 76 (7) 3105-3113 10.1128/JVI.76.7.3105-3113.2002
95. Sinha, S.; Grandgenett, D. P. Recombinant Human Immunodeficiency Virus Type 1 Integrase Exhibits a Capacity for Full-Site Integration in Vitro That Is Comparable to That of Purified Preintegration Complexes from Virus-Infected Cells J. Virol. 2005, 79 (13) 8208-8216 10.1128/JVI.79.13.8208-8216.2005
96. Li, M.; Craigie, R. Processing of Viral DNA Ends Channels the HIV-1 Integration Reaction to Concerted Integration J. Biol. Chem. 2005, 280 (32) 29334-29339 10.1074/jbc.M505367200
97. Hindmarsh, P.; Ridky, T.; Reeves, R.; Andrake, M.; Skalka, A. M.; Leis, J. HMG Protein Family Members Stimulate Human Immunodeficiency Virus Type 1 and Avian Sarcoma Virus Concerted DNA Integration in Vitro J. Virol. 1999, 73 (4) 2994-3003
98. Hare, S.; Shun, M. C.; Gupta, S. S.; Valkov, E.; Engelman, A.; Cherepanov, P. A Novel Co-Crystal Structure Affords the Design of Gain-of-Function Lentiviral Integrase Mutants in the Presence of Modified PSIP1/LEDGF/p75 PLoS Pathog. 2009, 5 (1) e1000259 10.1371/journal.ppat.1000259
99. Pandey, K. K.; Bera, S.; Grandgenett, D. P. The HIV-1 Integrase Monomer Induces a Specific Interaction with LTR DNA for Concerted Integration Biochemistry 2011, 50 (45) 9788-9796 10.1021/bi201247f
100. Li, M.; Ivanov, V.; Mizuuchi, M.; Mizuuchi, K.; Craigie, R. DNA Requirements for Assembly and Stability of HIV-1 Intasomes Protein Sci. 2012, 21, 249-257 10.1002/pro.2010
101. Li, M.; Jurado, K. A.; Lin, S.; Engelman, A.; Craigie, R. Engineered Hyperactive Integrase for Concerted HIV-1 DNA Integration PLoS One 2014, 9, e105078 10.1371/journal.pone.0105078
102. Cherepanov, P. LEDGF/p75 Interacts with Divergent Lentiviral Integrases and Modulates Their Enzymatic Activity in Vitro Nucleic Acids Res. 2007, 35 (1) 113-124 10.1093/nar/gkl885
103. Valkov, E.; Gupta, S. S.; Hare, S.; Helander, A.; Roversi, P.; McClure, M.; Cherepanov, P. Functional and Structural Characterization of the Integrase from the Prototype Foamy Virus Nucleic Acids Res. 2009, 37 (1) 243-255 10.1093/nar/gkn938
104. Ballandras-Colas, A.; Naraharisetty, H.; Li, X.; Serrao, E.; Engelman, A. Biochemical Characterization of Novel Retroviral Integrase Proteins PLoS One 2013, 8 (10) e76638 10.1371/journal.pone.0076638
105. Deprez, E.; Tauc, P.; Leh, H.; Mouscadet, J. F.; Auclair, C.; Brochon, J. C. Oligomeric States of the HIV-1 Integrase as Measured by Time-Resolved Fluorescence Anisotropy Biochemistry 2000, 39 (31) 9275-9284 10.1021/bi000397j
106. Chow, S. A.; Vincent, K. A.; Ellison, V.; Brown, P. O. Reversal of Integration and DNA Splicing Mediated by Integrase of Human Immunodeficiency Virus Science 1992, 255 (5045) 723-726 10.1126/science.1738845
107. van Gent, D. C.; Groeneger, A. A.; Plasterk, R. H. Mutational Analysis of the Integrase Protein of Human Immunodeficiency Virus Type 2 Proc. Natl. Acad. Sci. U. S. A. 1992, 89 (20) 9598-9602 10.1073/pnas.89.20.9598
108. Engelman, A.; Craigie, R. Identification of Conserved Amino Acid Residues Critical for Human Immunodeficiency Virus Type 1 Integrase Function in Vitro J. Virol. 1992, 66 (11) 6361-6369
109. Leavitt, A. D.; Shiue, L.; Varmus, H. E. Site-Directed Mutagenesis of HIV-1 Integrase Demonstrates Differential Effects on Integrase Functions in Vitro J. Biol. Chem. 1993, 268 (3) 2113-2119
110. Vink, C.; Oude Groeneger, A. M.; Plasterk, R. H. Identification of the Catalytic and DNA-Binding Region of the Human Immunodeficiency Virus Type I Integrase Protein Nucleic Acids Res. 1993, 21 (6) 1419-1425 10.1093/nar/21.6.1419
111. Gerton, J. L.; Brown, P. O. The Core Domain of HIV-1 Integrase Recognizes Key Features of Its DNA Substrates J. Biol. Chem. 1997, 272 (41) 25809-25815 10.1074/jbc.272.41.25809
112. Bushman, F. D.; Engelman, A.; Palmer, I.; Wingfield, P.; Craigie, R. Domains of the Integrase Protein of Human Immunodeficiency Virus Type 1 Responsible for Polynucleotidyl Transfer and Zinc Binding Proc. Natl. Acad. Sci. U. S. A. 1993, 90, 3428-3432 10.1073/pnas.90.8.3428
113. Bushman, F. D.; Wang, B. Rous Sarcoma Virus Integrase Protein: Mapping Functions for Catalysis and Substrate Binding J. Virol. 1994, 68, 2215-2223
114. Kulkosky, J.; Katz, R. A.; Merkel, G.; Skalka, A. M. Activities and Substrate Specificity of the Evolutionarily Conserved Central Domain of Retroviral Integrase Virology 1995, 206, 448-456 10.1016/S0042-6822(95)80060-3
115. Donzella, G. A.; Jonsson, C. B.; Roth, M. J. Coordinated Disintegration Reactions Mediated by Moloney Murine Leukemia Virus Integrase J. Virol. 1996, 70 (6) 3909-3921
116. Levchenko, I.; Luo, L.; Baker, T. A. Disassembly of the Mu Transposase Tetramer by the Clpx Chaperone Genes Dev. 1995, 9 (19) 2399-2408 10.1101/gad.9.19.2399
117. Burton, B. M.; Baker, T. A. Remodeling Protein Complexes: Insights from the AAA+ Unfoldase Clpx and Mu Transposase Protein Sci. 2005, 14, 1945-1954 10.1110/ps.051417505
118. Skalka, A. M.; Katz, R. A. Retroviral DNA Integration and the DNA Damage Response Cell Death Differ. 2005, 12, 971-978 10.1038/sj.cdd.4401573
119. Mulder, L. C.; Muesing, M. A. Degradation of HIV-1 Integrase by the N-End Rule Pathway J. Biol. Chem. 2000, 275 (38) 29749-29753 10.1074/jbc.M004670200
120. Devroe, E.; Engelman, A.; Silver, P. A. Intracellular Transport of Human Immunodeficiency Virus Type 1 Integrase J. Cell Sci. 2003, 116 (Pt 21) 4401-4408
121. Llano, M.; Delgado, S.; Vanegas, M.; Poeschla, E. M. Lens Epithelium-Derived Growth Factor/p75 Prevents Proteasomal Degradation of HIV-1 Integrase J. Biol. Chem. 2004, 279 (53) 55570-55577 10.1074/jbc.M408508200
122. Mulder, L. C.; Chakrabarti, L. A.; Muesing, M. A. Interaction of HIV-1 Integrase with DNA Repair Protein hRAD18 J. Biol. Chem. 2002, 277 (30) 27489-27493 10.1074/jbc.M203061200
123. Lloyd, A. G.; Tateishi, S.; Bieniasz, P. D.; Muesing, M. A.; Yamaizumi, M.; Mulder, L. C. Effect of DNA Repair Protein Rad18 on Viral Infection PLoS Pathog. 2006, 2 (5) e40 10.1371/journal.ppat.0020040
124. Mousnier, A.; Kubat, N.; Massias-Simon, A.; Segeral, E.; Rain, J. C.; Benarous, R.; Emiliani, S.; Dargemont, C. Von Hippel Lindau Binding Protein 1-Mediated Degradation of Integrase Affects HIV-1 Gene Expression at a Postintegration Step Proc. Natl. Acad. Sci. U. S. A. 2007, 104 (34) 13615-13620 10.1073/pnas.0705162104
125. Yoder, K. E.; Bushman, F. D. Repair of Gaps in Retroviral DNA Integration Intermediates J. Virol. 2000, 74 (23) 11191-11200 10.1128/JVI.74.23.11191-11200.2000
126. Faust, E. A.; Triller, H. Stimulation of Human Flap Endonuclease 1 by Human Immunodeficiency Virus Type 1 Integrase: Possible Role for Flap Endonuclease 1 in 5′-End Processing of Human Immunodeficiency Virus Type 1 Integration Intermediates J. Biomed. Sci. 2002, 9 (3) 273-287 10.1159/000059428
127. Brin, E.; Yi, J.; Skalka, A. M.; Leis, J. Modeling the Late Steps in HIV-1 Retroviral Integrase-Catalyzed DNA Integration J. Biol. Chem. 2000, 275 (50) 39287-39295 10.1074/jbc.M006929200
128. Rumbaugh, J. A.; Fuentes, G. M.; Bambara, R. A. Processing of an HIV Replication Intermediate by the Human DNA Replication Enzyme FEN1 J. Biol. Chem. 1998, 273 (44) 28740-28745 10.1074/jbc.273.44.28740
129. Studamire, B.; Goff, S. P. Host Proteins Interacting with the Moloney Murine Leukemia Virus Integrase: Multiple Transcriptional Regulators and Chromatin Binding Factors Retrovirology 2008, 5, 48 10.1186/1742-4690-5-48
130. Espeseth, A. S.; Fishel, R.; Hazuda, D.; Huang, Q.; Xu, M.; Yoder, K.; Zhou, H. siRNA Screening of a Targeted Library of DNA Repair Factors in HIV Infection Reveals a Role for Base Excision Repair in HIV Integration PLoS One 2011, 6, e17612 10.1371/journal.pone.0017612
131. Yoder, K. E.; Espeseth, A.; Wang, X. H.; Fang, Q.; Russo, M. T.; Lloyd, R. S.; Hazuda, D.; Sobol, R. W.; Fishel, R. The Base Excision Repair Pathway Is Required for Efficient Lentivirus Integration PLoS One 2011, 6, e17862 10.1371/journal.pone.0017862
132. Daniel, R.; Katz, R. A.; Merkel, G.; Hittle, J. C.; Yen, T. J.; Skalka, A. M. Wortmannin Potentiates Integrase-Mediated Killing of Lymphocytes and Reduces the Efficiency of Stable Transduction by Retroviruses Mol. Cell. Biol. 2001, 21 (4) 1164-1172 10.1128/MCB.21.4.1164-1172.2001
133. Daniel, R.; Katz, R. A.; Skalka, A. M. A Role for DNA-PK in Retroviral DNA Integration Science 1999, 284 (5414) 644-647 10.1126/science.284.5414.644
134. Cooper, A.; García, M.; Petrovas, C.; Yamamoto, T.; Koup, R. A.; Nabel, G. J. HIV-1 Causes CD4 Cell Death through DNA-Dependent Protein Kinase During Viral Integration Nature 2013, 498, 376-379 10.1038/nature12274
135. Majors, J. E.; Varmus, H. E. Nucleotide Sequences at Host-Proviral Junctions for Mouse Mammary Tumour Virus Nature 1981, 289 (5795) 253-258 10.1038/289253a0
136. Dhar, R.; McClements, W. L.; Enquist, L. W.; Vande Woude, G. F. Nucleotide Sequences of Integrated Moloney Sarcoma Provirus Long Terminal Repeats and Their Host and Viral Junctions Proc. Natl. Acad. Sci. U. S. A. 1980, 77, 3937-3941 10.1073/pnas.77.7.3937
137. Hishinuma, F.; DeBona, P. J.; Astrin, S.; Skalka, A. M. Nucleotide Sequence of Acceptor Site and Termini of Integrated Avian Endogenous Provirus Ev1: Integration Creates a 6 Bp Repeat of Host DNA Cell 1981, 23, 155-164 10.1016/0092-8674(81)90280-4
138. Hughes, S. H.; Mutschler, A.; Bishop, J. M.; Varmus, H. E. A Rous Sarcoma Virus Provirus Is Flanked by Short Direct Repeats of a Cellular DNA Sequence Present in Only One Copy Prior to Integration Proc. Natl. Acad. Sci. U. S. A. 1981, 78, 4299-5303 10.1073/pnas.78.7.4299
139. Chou, K. S.; Okayama, A.; Su, I. J.; Lee, T. H.; Essex, M. Preferred Nucleotide Sequence at the Integration Target Site of Human T-Cell Leukemia Virus Type I from Patients with Adult T-Cell Leukemia Int. J. Cancer 1996, 65, 20-24 10.1002/(SICI)1097-0215(19960103)65:1<20::AID-IJC4>3.3.CO;2-7
140. Chou, K. S.; Okayama, A.; Tachibana, N.; Lee, T. H.; Essex, M. Nucleotide Sequence Analysis of a Full-Length Human T-Cell Leukemia Virus Type I from Adult T-Cell Leukemia Cells: A Prematurely Terminated PX Open Reading Frame II Int. J. Cancer 1995, 60, 701-706 10.1002/ijc.2910600522
141. Schweizer, M.; Fleps, U.; Jäckle, A.; Renne, R.; Turek, R.; Neumann-Haefelin, D. Simian Foamy Virus Type 3 (SFV-3) in Latently Infected Vero Cells: Reactivation by Demethylation of Proviral DNA Virology 1993, 192, 663-666 10.1006/viro.1993.1084
142. Neves, M.; Périès, J.; Saïb, A. Study of Human Foamy Virus Proviral Integration in Chronically Infected Murine Cells Res. Virol. 1998, 149, 393-401 10.1016/S0923-2516(99)80007-7
143. Vincent, K. A.; York-Higgins, D.; Quiroga, M.; Brown, P. O. Host Sequences Flanking the HIV Provirus Nucleic Acids Res. 1990, 18 (20) 6045-6047 10.1093/nar/18.20.6045
144. Vink, C.; Groenink, M.; Elgersma, Y.; Fouchier, R. A.; Tersmette, M.; Plasterk, R. H. Analysis of the Junctions between Human Immunodeficiency Virus Type 1 Proviral DNA and Human DNA J. Virol. 1990, 64 (11) 5626-5627
145. Regier, D. A.; Desrosiers, R. C. The Complete Nucleotide Sequence of a Pathogenic Molecular Clone of Simian Immunodeficiency Virus AIDS Res. Hum. Retroviruses 1990, 6 (11) 1221-1231 10.1089/aid.1990.6.1221
146. Hacker, C. V.; Vink, C. A.; Wardell, T. W.; Lee, S.; Treasure, P.; Kingsman, S. M.; Mitrophanous, K. A.; Miskin, J. E. The Integration Profile of EIAV-Based Vectors Mol. Ther. 2006, 14 (4) 536-545 10.1016/j.ymthe.2006.06.006
147. Cai, M.; Zheng, R.; Caffrey, M.; Craigie, R.; Clore, G. M.; Gronenborn, A. M. Solution Structure of the N-Terminal Zinc Binding Domain of HIV-1 Integrase [Published Erratum Appears in Nat Struct Biol 1997 Oct;4(10):839-40] Nat. Struct. Biol. 1997, 4 (7) 567-577 10.1038/nsb0797-567
148. Dyda, F.; Hickman, A. B.; Jenkins, T. M.; Engelman, A.; Craigie, R.; Davies, D. R. Crystal Structure of the Catalytic Domain of HIV-1 Integrase: Similarity to Other Polynucleotidyl Transferases [See Comments] Science 1994, 266 (5193) 1981-1986 10.1126/science.7801124
149. Eijkelenboom, A. P.; Puras Lutzke, R. A.; Boelens, R.; Plasterk, R. H.; Kaptein, R.; Hard, K. The DNA-Binding Domain of HIV-1 Integrase Has an SH3-Like Fold Nat. Struct. Biol. 1995, 2 (9) 807-810 10.1038/nsb0995-807
150. Eijkelenboom, A. P.; van den Ent, F. M.; Vos, A.; Doreleijers, J. F.; Hard, K.; Tullius, T. D.; Plasterk, R. H.; Kaptein, R.; Boelens, R. The Solution Structure of the Amino-Terminal HHCC Domain of HIV-2 Integrase: A Three-Helix Bundle Stabilized by Zinc Curr. Biol. 1997, 7 (10) 739-746 10.1016/S0960-9822(06)00332-0
151. Lodi, P. J.; Ernst, J. A.; Kuszewski, J.; Hickman, A. B.; Engelman, A.; Craigie, R.; Clore, G. M.; Gronenborn, A. M. Solution Structure of the DNA Binding Domain of HIV-1 Integrase Biochemistry 1995, 34 (31) 9826-9833 10.1021/bi00031a002
152. Bujacz, G.; Jaskolski, M.; Alexandratos, J.; Wlodawer, A.; Merkel, G.; Katz, R. A.; Skalka, A. M. High-Resolution Structure of the Catalytic Domain of Avian Sarcoma Virus Integrase J. Mol. Biol. 1995, 253 (2) 333-346 10.1006/jmbi.1995.0556
153. Aiyer, S.; Rossi, P.; Malani, N.; Schneider, W. M.; Chandar, A.; Bushman, F. D.; Montelione, G. T.; Roth, M. J. Structural and Sequencing Analysis of Local Target DNA Recognition by MLV Integrase Nucleic Acids Res. 2015, 43 (11) 5647-5663 10.1093/nar/gkv410
154. Esposito, D.; Craigie, R. HIV Integrase Structure and Function Adv. Virus Res. 1999, 52, 319-333 10.1016/S0065-3527(08)60304-8
155. Ballandras-Colas, A.; Brown, M.; Cook, N. J.; Dewdney, T. G.; Demeler, B.; Cherepanov, P.; Lyumkis, D.; Engelman, A. N. Cryo-EM Reveals a Novel Octameric Integrase Structure for Betaretroviral Intasome Function Nature 2016, 530 (7590) 358-361 10.1038/nature16955
156. Hare, S.; Maertens, G. N.; Cherepanov, P. 3′-Processing and Strand Transfer Catalysed by Retroviral Integrase in Crystallo EMBO J. 2012, 31 (13) 3020-3028 10.1038/emboj.2012.118
157. Maertens, G. N.; Hare, S.; Cherepanov, P. The Mechanism of Retroviral Integration from X-Ray Structures of Its Key Intermediates Nature 2010, 468 (7321) 326-329 10.1038/nature09517
158. Li, X.; Krishnan, L.; Cherepanov, P.; Engelman, A. Structural Biology of Retroviral DNA Integration Virology 2011, 411, 194-205 10.1016/j.virol.2010.12.008
159. Kulkosky, J.; Jones, K. S.; Katz, R. A.; Mack, J. P.; Skalka, A. M. Residues Critical for Retroviral Integrative Recombination in a Region That Is Highly Conserved among Retroviral/Retrotransposon Integrases and Bacterial Insertion Sequence Transposases Mol. Cell. Biol. 1992, 12 (5) 2331-2338 10.1128/MCB.12.5.2331
160. Nowotny, M. Retroviral Integrase Superfamily: The Structural Perspective EMBO Rep. 2009, 10 (2) 144-151 10.1038/embor.2008.256
161. Kuo, C. F.; Zou, A. H.; Jayaram, M.; Getzoff, E.; Harshey, R. DNA-Protein Complexes During Attachment-Site Synapsis in Mu DNA Transposition EMBO J. 1991, 10 (6) 1585-1591
162. Harshey, R. M. The Mu Story: How a Maverick Phage Moved the Field Forward Mobile DNA 2012, 3 (1) 21 10.1186/1759-8753-3-21
163. Baker, T. A.; Mizuuchi, M.; Savilahti, H.; Mizuuchi, K. Division of Labor among Monomers within the Mu Transposase Tetramer Cell 1993, 74 (4) 723-733 10.1016/0092-8674(93)90519-V
164. Jacks, T.; Power, M. D.; Masiarz, F. R.; Luciw, P. A.; Barr, P. J.; Varmus, H. E. Characterization of Ribosomal Frameshifting in HIV-1 Gag-Pol Expression Nature 1988, 331, 280-283 10.1038/331280a0
165. Briggs, J. A.; Simon, M. N.; Gross, I.; Kräusslich, H. G.; Fuller, S. D.; Vogt, V. M.; Johnson, M. C. The Stoichiometry of Gag Protein in HIV-1 Nat. Struct. Mol. Biol. 2004, 11, 672-675 10.1038/nsmb785
166. van Gent, D. C.; Elgersma, Y.; Bolk, M. W. J.; Vink, C.; Plasterk, R. H. A. DNA Binding Properties of the Integrase Proteins of Human Immunodeficiency Viruses Types 1 and 2 Nucleic Acids Res. 1991, 19 (14) 3821-3827 10.1093/nar/19.14.3821
167. Vincent, K. A.; Ellison, V.; Chow, S. A.; Brown, P. O. Characterization of Human Immunodeficiency Virus Type 1 Integrase Expressed in Escherichia Coli and Analysis of Variants with Amino-Terminal Mutations J. Virol. 1993, 67 (1) 425-437
168. Engelman, A.; Bushman, F. D.; Craigie, R. Identification of Discrete Functional Domains of HIV-1 Integrase and Their Organization within an Active Multimeric Complex EMBO J. 1993, 12, 3269-3275
169. Li, M.; Mizuuchi, M.; Burke, T. R., Jr.; Craigie, R. Retroviral DNA Integration: Reaction Pathway and Critical Intermediates EMBO J. 2006, 25 (6) 1295-1304 10.1038/sj.emboj.7601005
170. Faure, A.; Calmels, C.; Desjobert, C.; Castroviejo, M.; Caumont-Sarcos, A.; Tarrago-Litvak, L.; Litvak, S.; Parissi, V. HIV-1 Integrase Crosslinked Oligomers Are Active in Vitro Nucleic Acids Res. 2005, 33 (3) 977-986 10.1093/nar/gki241
171. Cherepanov, P.; Maertens, G.; Proost, P.; Devreese, B.; Van Beeumen, J.; Engelborghs, Y.; De Clercq, E.; Debyser, Z. HIV-1 Integrase Forms Stable Tetramers and Associates with LEDGF/p75 Protein in Human Cells J. Biol. Chem. 2003, 278 (1) 372-381
172. Bera, S.; Pandey, K. K.; Vora, A. C.; Grandgenett, D. P. Molecular Interactions between HIV-1 Integrase and the Two Viral DNA Ends within the Synaptic Complex That Mediates Concerted Integration J. Mol. Biol. 2009, 389, 183-198 10.1016/j.jmb.2009.04.007
173. Hickman, A. B.; Ewis, H. E.; Li, X.; Knapp, J. A.; Laver, T.; Doss, A. L.; Tolun, G.; Steven, A. C.; Grishaev, A.; Bax, A. et al. Structural Basis of Hat Transposon End Recognition by Hermes, an Octameric DNA Transposase from Musca Domestica Cell 2014, 158 (2) 353-367 10.1016/j.cell.2014.05.037
174. Baker, T. A.; Mizuuchi, K. DNA-Promoted Assembly of the Active Tetramer of the Mu Transposase Genes Dev. 1992, 6 (11) 2221-2232 10.1101/gad.6.11.2221
175. Bhasin, A.; Goryshin, I. Y.; Steiniger-White, M.; York, D.; Reznikoff, W. S. Characterization of a Tn5 Pre-Cleavage Synaptic Complex J. Mol. Biol. 2000, 302 (1) 49-63 10.1006/jmbi.2000.4048
176. Richardson, J. M.; Colloms, S. D.; Finnegan, D. J.; Walkinshaw, M. D. Molecular Architecture of the Mos1 Paired-End Complex: The Structural Basis of DNA Transposition in a Eukaryote Cell 2009, 138 (6) 1096-1108 10.1016/j.cell.2009.07.012
177. Montano, S. P.; Pigli, Y. Z.; Rice, P. A. The Mu Transpososome Structure Sheds Light on DDE Recombinase Evolution Nature 2012, 491 (7424) 413-417 10.1038/nature11602
178. Lee, S. P.; Xiao, J.; Knutson, J. R.; Lewis, M. S.; Han, M. K. Zn2+ Promotes the Self-Association of Human Immunodeficiency Virus Type-1 Integrase in Vitro Biochemistry 1997, 36 (1) 173-180 10.1021/bi961849o
179. Heuer, T. S.; Brown, P. O. Photo-Cross-Linking Studies Suggest a Model for the Architecture of an Active Human Immunodeficiency Virus Type 1 Integrase-DNA Complex Biochemistry 1998, 37 (19) 6667-6678 10.1021/bi972949c
180. Gupta, K.; Curtis, J. E.; Krueger, S.; Hwang, Y.; Cherepanov, P.; Bushman, F. D.; Van Duyne, G. D. Solution Conformations of Prototype Foamy Virus Integrase and Its Stable Synaptic Complex with U5 Viral DNA Structure 2012, 20 (11) 1918-1928 10.1016/j.str.2012.08.023
181. Yin, Z.; Shi, K.; Banerjee, S.; Pandey, K. K.; Bera, S.; Grandgenett, D. P.; Aihara, H. Crystal Structure of the Rous Sarcoma Virus Intasome Nature 2016, 530 (7590) 362-366 10.1038/nature16950
182. van Gent, D. C.; Vink, C.; Groeneger, A. A.; Plasterk, R. H. Complementation between HIV Integrase Proteins Mutated in Different Domains EMBO J. 1993, 12, 3261-3267
183. Pahl, A.; Flügel, R. M. Characterization of the Human Spuma Retrovirus Integrase by Site-Directed Mutagenesis, by Complementation Analysis, and by Swapping the Zinc Finger Domain of HIV-1 J. Biol. Chem. 1995, 270 (7) 2957-2966 10.1074/jbc.270.7.2957
184. Jonsson, C. B.; Donzella, G. A.; Gaucan, E.; Smith, C. M.; Roth, M. J. Functional Domains of Moloney Murine Leukemia Virus Integrase Defined by Mutation and Complementation Analysis J. Virol. 1996, 70 (7) 4585-4597
185. Wang, J. Y.; Ling, H.; Yang, W.; Craigie, R. Structure of a Two-Domain Fragment of HIV-1 Integrase: Implications for Domain Organization in the Intact Protein EMBO J. 2001, 20 (24) 7333-7343 10.1093/emboj/20.24.7333
186. Hare, S.; Di Nunzio, F.; Labeja, A.; Wang, J.; Engelman, A.; Cherepanov, P. Structural Basis for Functional Tetramerization of Lentiviral Integrase PLoS Pathog. 2009, 5 (7) e1000515 10.1371/journal.ppat.1000515
187. Jaskolski, M.; Alexandratos, J. N.; Bujacz, G.; Wlodawer, A. Piecing Together the Structure of Retroviral Integrase, an Important Target in AIDS Therapy FEBS J. 2009, 276 (11) 2926-2946 10.1111/j.1742-4658.2009.07009.x
188. Engelman, A.; Cherepanov, P. Retroviral Integrase Structure and DNA Recombination Mechanism Microbiol. Spectr. 2014, 2, 1-22
189. Delelis, O.; Carayon, K.; Guiot, E.; Leh, H.; Tauc, P.; Brochon, J. C.; Mouscadet, J. F.; Deprez, E. Insight into the Integrase-DNA Recognition Mechanism. A Specific DNA-Binding Mode Revealed by an Enzymatically Labeled Integrase J. Biol. Chem. 2008, 283 (41) 27838-27849 10.1074/jbc.M803257200
190. Yin, Z.; Lapkouski, M.; Yang, W.; Craigie, R. Assembly of Prototype Foamy Virus Strand Transfer Complexes on Product DNA Bypassing Catalysis of Integration Protein Sci. 2012, 21 (12) 1849-1857 10.1002/pro.2166
191. Maskell, D. P.; Renault, L.; Serrao, E.; Lesbats, P.; Matadeen, R.; Hare, S.; Lindemann, D.; Engelman, A. N.; Costa, A.; Cherepanov, P. Structural Basis for Retroviral Integration into Nucleosomes Nature 2015, 523, 366-369 10.1038/nature14495
192. Li, M.; Lin, S.; Craigie, R. Outer Domains of Integrase within Retroviral Intasomes Are Dispensible for Catalysis of DNA Integration Protein Sci. 2016, 25 (2) 472-478 10.1002/pro.2837
193. Holman, A. G.; Coffin, J. M. Symmetrical Base Preferences Surrounding HIV-1, Avian Sarcoma/Leukosis Virus, and Murine Leukemia Virus Integration Sites Proc. Natl. Acad. Sci. U. S. A. 2005, 102 (17) 6103-6107 10.1073/pnas.0501646102
194. Serrao, E.; Ballandras-Colas, A.; Cherepanov, P.; Maertens, G. N.; Engelman, A. N. Key Determinants of Target DNA Recognition by Retroviral Intasomes Retrovirology 2015, 12, 39 10.1186/s12977-015-0167-3
195. Pruss, D.; Bushman, F. D.; Wolffe, A. P. Human Immunodeficiency Virus Integrase Directs Integration to Sites of Severe DNA Distortion within the Nucleosome Core Proc. Natl. Acad. Sci. U. S. A. 1994, 91 (13) 5913-5917 10.1073/pnas.91.13.5913
196. Pruss, D.; Reeves, R.; Bushman, F. D.; Wolffe, A. P. The Influence of DNA and Nucleosome Structure on Integration Events Directed by HIV Integrase J. Biol. Chem. 1994, 269 (40) 25031-25041
197. Benleulmi, M. S.; Matysiak, J.; Henriquez, D. R.; Vaillant, C.; Lesbats, P.; Calmels, C.; Naughtin, M.; Leon, O.; Skalka, A. M.; Ruff, M. et al. Intasome Architecture and Chromatin Density Modulate Retroviral Integration into Nucleosome Retrovirology 2015, 12, 13 10.1186/s12977-015-0145-9
198. Pryciak, P. M.; Sil, A.; Varmus, H. E. Retroviral Integration into Minichromosomes in Vitro EMBO J. 1992, 11 (1) 291-303
199. Pryciak, P. M.; Müller, H.-P.; Varmus, H. E. Simian Virus 40 minichromosomes as Targets for Retroviral Integration in Vivo Proc. Natl. Acad. Sci. U. S. A. 1992, 89 (19) 9237-9241 10.1073/pnas.89.19.9237
200. Pryciak, M. P.; Varmus, E. H. Nucleosomes, DNA-Binding Proteins, and DNA Sequence Modulate Retroviral Integration Target Site Selection Cell 1992, 69, 769-780 10.1016/0092-8674(92)90289-O
201. Wang, G. P.; Ciuffi, A.; Leipzig, J.; Berry, C. C.; Bushman, F. D. HIV Integration Site Selection: Analysis by Massively Parallel Pyrosequencing Reveals Association with Epigenetic Modifications Genome Res. 2007, 17 (8) 1186-1194 10.1101/gr.6286907
202. Roth, S. L.; Malani, N.; Bushman, F. D. Gammaretroviral Integration into Nucleosomal Target DNA in Vivo J. Virol. 2011, 85 (14) 7393-7401 10.1128/JVI.00635-11
203. Luger, K.; Mader, A. W.; Richmond, R. K.; Sargent, D. F.; Richmond, T. J. Crystal Structure of the Nucleosome Core Particle at 2.8 A Resolution Nature 1997, 389 (6648) 251-260 10.1038/38444
204. Greenwald, J.; Le, V.; Butler, S. L.; Bushman, F. D.; Choe, S. The Mobility of an HIV-1 Integrase Active Site Loop Is Correlated with Catalytic Activity Biochemistry 1999, 38 (28) 8892-8898 10.1021/bi9907173
205. Krishnan, L.; Li, X.; Naraharisetty, H. L.; Hare, S.; Cherepanov, P.; Engelman, A. Structure-Based Modeling of the Functional HIV-1 Intasome and Its Inhibition Proc. Natl. Acad. Sci. U. S. A. 2010, 107 (36) 15910-15915 10.1073/pnas.1002346107
206. Hare, S.; Vos, A. M.; Clayton, R. F.; Thuring, J. W.; Cummings, M. D.; Cherepanov, P. Molecular Mechanisms of Retroviral Integrase Inhibition and the Evolution of Viral Resistance Proc. Natl. Acad. Sci. U. S. A. 2010, 107 (46) 20057-20062 10.1073/pnas.1010246107
207. Engelman, A.; Craigie, R. Efficient Magnesium-Dependent Human Immunodeficiency Virus Type 1 Integrase Activity J. Virol. 1995, 69 (9) 5908-5911
208. Yang, W.; Lee, J. Y.; Nowotny, M. Making and Breaking Nucleic Acids: Two-Mg2+-Ion Catalysis and Substrate Specificity Mol. Cell 2006, 22 (1) 5-13 10.1016/j.molcel.2006.03.013
209. Beese, L. S.; Steitz, T. A. Structural Basis for the 3′-5′ Exonuclease Activity of Escherichia Coli DNA Polymerase I: A Two Metal Ion Mechanism EMBO J. 1991, 10 (1) 25-33
210. Steitz, T. A.; Steitz, J. A. A General Two-Metal-Ion Mechanism for Catalytic RNA Proc. Natl. Acad. Sci. U. S. A. 1993, 90 (14) 6498-6502 10.1073/pnas.90.14.6498
211. Nowotny, M.; Gaidamakov, S. A.; Crouch, R. J.; Yang, W. Crystal Structures of RNase H Bound to an RNA/DNA Hybrid: Substrate Specificity and Metal-Dependent Catalysis Cell 2005, 121 (7) 1005-1016 10.1016/j.cell.2005.04.024
212. Nowotny, M.; Yang, W. Stepwise Analyses of Metal Ions in RNase H Catalysis from Substrate Destabilization to Product Release EMBO J. 2006, 25 (9) 1924-1933 10.1038/sj.emboj.7601076
213. Rosta, E.; Nowotny, M.; Yang, W.; Hummer, G. Catalytic Mechanism of RNA Backbone Cleavage by Ribonuclease H from Quantum Mechanics/Molecular Mechanics Simulations J. Am. Chem. Soc. 2011, 133 (23) 8934-8941 10.1021/ja200173a
214. Madhusudan; Akamine, P.; Xuong, N. H.; Taylor, S. S. Crystal Structure of a Transition State Mimic of the Catalytic Subunit of Camp-Dependent Protein Kinase Nat. Struct. Biol. 2002, 9 (4) 273-277 10.1038/nsb780
215. Bao, Z. Q.; Jacobsen, D. M.; Young, M. A. Briefly Bound to Activate: Transient Binding of a Second Catalytic Magnesium Activates the Structure and Dynamics of Cdk2 Kinase for Catalysis Structure 2011, 19 (5) 675-690 10.1016/j.str.2011.02.016
216. Bastidas, A. C.; Deal, M. S.; Steichen, J. M.; Guo, Y.; Wu, J.; Taylor, S. S. Phosphoryl Transfer by Protein Kinase a Is Captured in a Crystal Lattice J. Am. Chem. Soc. 2013, 135 (12) 4788-4798 10.1021/ja312237q
217. Doublie, S.; Tabor, S.; Long, A. M.; Richardson, C. C.; Ellenberger, T. Crystal Structure of a Bacteriophage T7 DNA Replication Complex at 2.2 A Resolution Nature 1998, 391 (6664) 251-258 10.1038/34593
218. Yin, Y. W.; Steitz, T. A. The Structural Mechanism of Translocation and Helicase Activity in T7 RNA Polymerase Cell 2004, 116 (3) 393-404 10.1016/S0092-8674(04)00120-5
219. Stahley, M. R.; Strobel, S. A. Structural Evidence for a Two-Metal-Ion Mechanism of Group I Intron Splicing Science 2005, 309 (5740) 1587-1590 10.1126/science.1114994
220. Gangadharan, S.; Mularoni, L.; Fain-Thornton, J.; Wheelan, S. J.; Craig, N. L. DNA Transposon Hermes Inserts into DNA in Nucleosome-Free Regions in Vivo Proc. Natl. Acad. Sci. U. S. A. 2010, 107 (51) 21966-21972 10.1073/pnas.1016382107
221. Pribil, P. A.; Haniford, D. B. Target DNA Bending Is an Important Specificity Determinant in Target Site Selection in Tn10 Transposition J. Mol. Biol. 2003, 330 (2) 247-259 10.1016/S0022-2836(03)00588-6
222. Hallet, B.; Rezsohazy, R.; Mahilton, J.; Delcour, J. IS231A Insertion Specificity: Consensus Sequence and DNA Bending at the Target Site Mol. Microbiol. 1994, 14 (1) 131-139 10.1111/j.1365-2958.1994.tb01273.x
223. Johnson, B. C.; Métifiot, M.; Ferris, A.; Pommier, Y.; Hughes, S. H. A Homology Model of HIV-1 Integrase and Analysis of Mutations Designed to Test the Model J. Mol. Biol. 2013, 425, 2133-2146 10.1016/j.jmb.2013.03.027
224. Jordan, A.; Defechereux, P.; Verdin, E. The Site of HIV-1 Integration in the Human Genome Determines Basal Transcriptional Activity and Response to Tat Transactivation EMBO J. 2001, 20 (7) 1726-1738 10.1093/emboj/20.7.1726
225. Jordan, A.; Bisgrove, D.; Verdin, E. HIV Reproducibly Establishes a Latent Infection after Acute Infection of T Cells in Vitro EMBO J. 2003, 22 (8) 1868-1877 10.1093/emboj/cdg188
226. Gerard, A.; Segeral, E.; Naughtin, M.; Abdouni, A.; Charmeteau, B.; Cheynier, R.; Rain, J. C.; Emiliani, S. The Integrase Cofactor LEDGF/p75 Associates with Iws1 and Spt6 for Postintegration Silencing of HIV-1 Gene Expression in Latently Infected Cells Cell Host Microbe 2015, 17 (1) 107-117 10.1016/j.chom.2014.12.002
227. Maldarelli, F.; Wu, X.; Su, L.; Simonetti, F. R.; Shao, W.; Hill, S.; Spindler, J.; Ferris, A. L.; Mellors, J. W.; Kearney, M. F. et al. Specific HIV Integration Sites Are Linked to Clonal Expansion and Persistence of Infected Cells Science 2014, 345 (6193) 179-183 10.1126/science.1254194
228. Wagner, T. A.; McLaughlin, S.; Garg, K.; Cheung, C. Y.; Larsen, B. B.; Styrchak, S.; Huang, H. C.; Edlefsen, P. T.; Mullins, J. I.; Frenkel, L. M. Proliferation of Cells with HIV Integrated into Cancer Genes Contributes to Persistent Infection Science 2014, 345 (6196) 570-573 10.1126/science.1256304
229. Wong, J. K.; Hezareh, M.; Gunthard, H. F.; Havlir, D. V.; Ignacio, C. C.; Spina, C. A.; Richman, D. D. Recovery of Replication-Competent HIV Despite Prolonged Suppression of Plasma Viremia Science 1997, 278 (5341) 1291-1295 10.1126/science.278.5341.1291
230. Finzi, D.; Blankson, J.; Siliciano, J. D.; Margolick, J. B.; Chadwick, K.; Pierson, T.; Smith, K.; Lisziewicz, J.; Lori, F.; Flexner, C. et al. Latent Infection of CD4+ T Cells Provides a Mechanism for Lifelong Persistence of HIV-1, Even in Patients on Effective Combination Therapy Nat. Med. 1999, 5 (5) 512-517 10.1038/8394
231. Wu, X.; Li, Y.; Crise, B.; Burgess, S. M.; Munroe, D. J. Weak Palindromic Consensus Sequences Are a Common Feature Found at the Integration Target Sites of Many Retroviruses J. Virol. 2005, 79 (8) 5211-5214 10.1128/JVI.79.8.5211-5214.2005
232. Stevens, S. W.; Griffith, J. D. Sequence Analysis of the Human DNA Flanking Sites of Human Immunodeficiency Virus Type 1 Integration J. Virol. 1996, 70 (9) 6459-6462
233. Stevens, S. W.; Griffith, J. D. Human Immunodeficiency Virus Type 1 May Preferentially Integrate into Chromatin Occupied by L1Hs Repetitive Elements Proc. Natl. Acad. Sci. U. S. A. 1994, 91 (12) 5557-5561 10.1073/pnas.91.12.5557
234. Panet, A.; Cedar, H. Selective Degradation of Integrated Murine Leukemia Proviral DNA by Deoxyribonucleases Cell 1977, 11 (4) 933-940 10.1016/0092-8674(77)90304-X
235. Vijaya, S.; Steffen, D. L.; Robinson, H. L. Acceptor Sites for Retroviral Integrations Map near DNase I-Hypersensitive Sites in Chromatin J. Virol. 1986, 60 (2) 683-692
236. Rohdewohld, H.; Weiher, H.; Reik, W.; Jaenisch, R.; Breindl, M. Retrovirus Integration and Chromatin Structure: Moloney Murine Leukemia Proviral Integration Sites Map near DNase I-Hypersensitive Sites J. Virol. 1987, 61 (2) 336-343
237. Venter, J. C.; Adams, M. D.; Myers, E. W.; Li, P. W.; Mural, R. J.; Sutton, G. G.; Smith, H. O.; Yandell, M.; Evans, C. A.; Holt, R. A. et al. The Sequence of the Human Genome Science 2001, 291 (5507) 1304-1351 10.1126/science.1058040
238. Lander, E. S.; Linton, L. M.; Birren, B.; Nusbaum, C.; Zody, M. C.; Baldwin, J.; Devon, K.; Dewar, K.; Doyle, M.; FitzHugh, W. et al. Initial Sequencing and Analysis of the Human Genome Nature 2001, 409 (6822) 860-921 10.1038/35057062
239. Schroder, A. R.; Shinn, P.; Chen, H.; Berry, C.; Ecker, J. R.; Bushman, F. HIV-1 Integration in the Human Genome Favors Active Genes and Local Hotspots Cell 2002, 110 (4) 521-529 10.1016/S0092-8674(02)00864-4
240. Singh, P. K.; Plumb, M. R.; Ferris, A. L.; Iben, J. R.; Wu, X.; Fadel, H. J.; Luke, B. T.; Esnault, C.; Poeschla, E. M.; Hughes, S. H. et al. LEDGF/p75 Interacts with mRNA Splicing Factors and Targets HIV-1 Integration to Highly Spliced Genes Genes Dev. 2015, 29 (21) 2287-2297 10.1101/gad.267609.115
241. De Ravin, S. S.; Su, L.; Theobald, N.; Choi, U.; Macpherson, J. L.; Poidinger, M.; Symonds, G.; Pond, S. M.; Ferris, A. L.; Hughes, S. H. et al. Enhancers Are Major Targets for Murine Leukemia Virus Vector Integration J. Virol. 2014, 88 (8) 4504-4513 10.1128/JVI.00011-14
242. LaFave, M. C.; Varshney, G. K.; Gildea, D. E.; Wolfsberg, T. G.; Baxevanis, A. D.; Burgess, S. M. MLV Integration Site Selection Is Driven by Strong Enhancers and Active Promoters Nucleic Acids Res. 2014, 42 (7) 4257-4269 10.1093/nar/gkt1399
243. Kvaratskhelia, M.; Sharma, A.; Larue, R. C.; Serrao, E.; Engelman, A. Molecular Mechanisms of Retroviral Integration Site Selection Nucleic Acids Res. 2014, 42 (16) 10209-10225 10.1093/nar/gku769
244. Mitchell, R. S.; Beitzel, B. F.; Schroder, A. R.; Shinn, P.; Chen, H.; Berry, C. C.; Ecker, J. R.; Bushman, F. D. Retroviral DNA Integration: ASLV, HIV, and MLV Show Distinct Target Site Preferences PLoS Biol. 2004, 2 (8) e234 10.1371/journal.pbio.0020234
245. Wu, X.; Li, Y.; Crise, B.; Burgess, S. M. Transcription Start Regions in the Human Genome Are Favored Targets for MLV Integration Science 2003, 300 (5626) 1749-1751 10.1126/science.1083413
246. Lewinski, M. K.; Yamashita, M.; Emerman, M.; Ciuffi, A.; Marshall, H.; Crawford, G.; Collins, F.; Shinn, P.; Leipzig, J.; Hannenhalli, S. et al. Retroviral DNA Integration: Viral and Cellular Determinants of Target-Site Selection PLoS Pathog. 2006, 2 (6) e60 10.1371/journal.ppat.0020060
247. Trobridge, G. D.; Miller, D. G.; Jacobs, M. A.; Allen, J. M.; Kiem, H.-P.; Kaul, R.; Russell, D. W. Foamy Virus Vector Integration Sites in Normal Human Cells Proc. Natl. Acad. Sci. U. S. A. 2006, 103 (5) 1498-1503 10.1073/pnas.0510046103
248. Nowrouzi, A.; Dittrich, M.; Klanke, C.; Heinkelein, M.; Rammling, M.; Dandekar, T.; von Kalle, C.; Rethwilm, A. Genome-Wide Mapping of Foamy Virus Vector Integrations into a Human Cell Line J. Gen. Virol. 2006, 87, 1339-1347 10.1099/vir.0.81554-0
249. Faschinger, A.; Rouault, F.; Sollner, J.; Lukas, A.; Salmons, B.; Gunzburg, W. H.; Indik, S. Mouse Mammary Tumor Virus Integration Site Selection in Human and Mouse Genomes J. Virol. 2008, 82 (3) 1360-1367 10.1128/JVI.02098-07
250. Narezkina, A.; Taganov, K. D.; Litwin, S.; Stoyanova, R.; Hayashi, J.; Seeger, C.; Skalka, A. M.; Katz, R. A. Genome-Wide Analyses of Avian Sarcoma Virus Integration Sites J. Virol. 2004, 78 (21) 11656-11663 10.1128/JVI.78.21.11656-11663.2004
251. Koh, Y.; Wu, X.; Ferris, A. L.; Matreyek, K. A.; Smith, S. J.; Lee, K.; KewalRamani, V. N.; Hughes, S. H.; Engelman, A. Differential Effects of Human Immunodeficiency Virus Type 1 Capsid and Cellular Factors Nucleoporin 153 and LEDGF/p75 on the Efficiency and Specificity of Viral DNA Integration J. Virol. 2013, 87 (1) 648-658 10.1128/JVI.01148-12
252. Schaller, T.; Ocwieja, K. E.; Rasaiyaah, J.; Price, A. J.; Brady, T. L.; Roth, S. L.; Hue, S.; Fletcher, A. J.; Lee, K.; KewalRamani, V. N. et al. HIV-1 Capsid-Cyclophilin Interactions Determine Nuclear Import Pathway, Integration Targeting and Replication Efficiency PLoS Pathog. 2011, 7 (12) e1002439 10.1371/journal.ppat.1002439
253. Bukrinsky, M. I.; Sharova, N.; Dempsey, M. P.; Stanwick, T. L.; Bukrinskaya, A. G.; Haggerty, S.; Stevenson, M. Active Nuclear Import of Human Immunodeficiency Virus Type 1 Preintegration Complexes Proc. Natl. Acad. Sci. U. S. A. 1992, 89, 6580-6584 10.1073/pnas.89.14.6580
254. Lewis, P.; Hensel, M.; Emerman, M. Human Immunodeficiency Virus Infection of Cells Arrested in the Cell Cycle EMBO J. 1992, 11, 3053-3058
255. Roe, T.; Reynolds, T. C.; Yu, G.; Brown, P. O. Integration of Murine Leukemia Virus DNA Depends on Mitosis EMBO J. 1993, 12 (5) 2099-2108
256. Lewis, P. F.; Emerman, M. Passage through Mitosis Is Required for Oncoretroviruses but Not for the Human Immunodeficiency Virus J. Virol. 1994, 68 (1) 510-516
257. Hatziioannou, T.; Goff, S. P. Infection of Nondividing Cells by Rous Sarcoma Virus J. Virol. 2001, 75 (19) 9526-9531 10.1128/JVI.75.19.9526-9531.2001
258. Katz, R. A.; Greger, J. G.; Darby, K.; Boimel, P.; Rall, G. F.; Skalka, A. M. Transduction of Interphase Cells by Avian Sarcoma Virus J. Virol. 2002, 76 (11) 5422-5434 10.1128/JVI.76.11.5422-5434.2002
259. Mergia, A.; Chari, S.; Kolson, D. L.; Goodenow, M. M.; Ciccarone, T. The Efficiency of Simian Foamy Virus Vector Type-1 (SFV-1) in Nondividing Cells and in Human PBLs Virology 2001, 280, 243-252 10.1006/viro.2000.0773
260. Lee, K.; Ambrose, Z.; Martin, T. D.; Oztop, I.; Mulky, A.; Julias, J. G.; Vandegraaff, N.; Baumann, J. G.; Wang, R.; Yuen, W. et al. Flexible Use of Nuclear Import Pathways by HIV-1 Cell Host Microbe 2010, 7, 221-233 10.1016/j.chom.2010.02.007
261. Price, A. J.; Fletcher, A. J.; Schaller, T.; Elliott, T.; Lee, K.; KewalRamani, V. N.; Chin, J. W.; Towers, G. J.; James, L. C. CPSF6 Defines a Conserved Capsid Interface That Modulates HIV-1 Replication PLoS Pathog. 2012, 8 (8) e1002896 10.1371/journal.ppat.1002896
262. Ocwieja, K. E.; Brady, T. L.; Ronen, K.; Huegel, A.; Roth, S. L.; Schaller, T.; James, L. C.; Towers, G. J.; Young, J. A.; Chanda, S. K. et al. HIV Integration Targeting: A Pathway Involving Transportin-3 and the Nuclear Pore Protein RanBP2 PLoS Pathog. 2011, 7 (3) e1001313 10.1371/journal.ppat.1001313
263. Matreyek, K. A.; Yucel, S. S.; Li, X.; Engelman, A. Nucleoporin NUP153 Phenylalanine-Glycine Motifs Engage a Common Binding Pocket within the HIV-1 Capsid Protein to Mediate Lentiviral Infectivity PLoS Pathog. 2013, 9 (10) e1003693 10.1371/journal.ppat.1003693
264. Di Nunzio, F.; Fricke, T.; Miccio, A.; Valle-Casuso, J. C.; Perez, P.; Souque, P.; Rizzi, E.; Severgnini, M.; Mavilio, F.; Charneau, P. et al. Nup153 and Nup98 Bind the HIV-1 Core and Contribute to the Early Steps of HIV-1 Replication Virology 2013, 440 (1) 8-18 10.1016/j.virol.2013.02.008
265. Sowd, G. A.; Serrao, E.; Wang, H.; Wang, W.; Fadel, H. J.; Poeschla, E. M.; Engelman, A. N. A Critical Role for Alternative Polyadenylation Factor CPSF6 in Targeting HIV-1 Integration to Transcriptionally Active Chromatin Proc. Natl. Acad. Sci. U. S. A. 2016, 113 (8) E1054-1063 10.1073/pnas.1524213113
266. Di Primio, C.; Quercioli, V.; Allouch, A.; Gijsbers, R.; Christ, F.; Debyser, Z.; Arosio, D.; Cereseto, A. Single-Cell Imaging of HIV-1 Provirus (SCIP) Proc. Natl. Acad. Sci. U. S. A. 2013, 110 (14) 5636-5641 10.1073/pnas.1216254110
267. Marini, B.; Kertesz-Farkas, A.; Ali, H.; Lucic, B.; Lisek, K.; Manganaro, L.; Pongor, S.; Luzzati, R.; Recchia, A.; Mavilio, F. et al. Nuclear Architecture Dictates HIV-1 Integration Site Selection Nature 2015, 521 (7551) 227-231 10.1038/nature14226
268. Nishizawa, Y.; Usukura, J.; Singh, D. P.; Chylack, L. T., Jr.; Shinohara, T. Spatial and Temporal Dynamics of Two Alternatively Spliced Regulatory Factors, Lens Epithelium-Derived Growth Factor (Ledgf/p75) and p52, in the Nucleus Cell Tissue Res. 2001, 305 (1) 107-114 10.1007/s004410100398
269. Ge, H.; Si, Y.; Roeder, R. G. Isolation of cDNAs Encoding Novel Transcription Coactivators p52 and p75 Reveals an Alternate Regulatory Mechanism of Transcriptional Activation EMBO J. 1998, 17 (22) 6723-6729 10.1093/emboj/17.22.6723
270. Singh, D. P.; Kimura, A.; Chylack, L. T., Jr.; Shinohara, T. Lens Epithelium-Derived Growth Factor (LEDGF/p75) and p52 Are Derived from a Single Gene by Alternative Splicing Gene 2000, 242 (1-2) 265-273 10.1016/S0378-1119(99)00506-5
271. Emiliani, S.; Mousnier, A.; Busschots, K.; Maroun, M.; Van Maele, B.; Tempe, D.; Vandekerckhove, L.; Moisant, F.; Ben-Slama, L.; Witvrouw, M. et al. Integrase Mutants Defective for Interaction with LEDGF/p75 Are Impaired in Chromosome Tethering and HIV-1 Replication J. Biol. Chem. 2005, 280 (27) 25517-25523 10.1074/jbc.M501378200
272. Busschots, K.; Vercammen, J.; Emiliani, S.; Benarous, R.; Engelborghs, Y.; Christ, F.; Debyser, Z. The Interaction of LEDGF/p75 with Integrase Is Lentivirus-Specific and Promotes DNA Binding J. Biol. Chem. 2005, 280 (18) 17841-17847 10.1074/jbc.M411681200
273. Pandey, K. K.; Sinha, S.; Grandgenett, D. P. Transcriptional Coactivator LEDGF/p75 Modulates Human Immunodeficiency Virus Type 1 Integrase-Mediated Concerted Integration J. Virol. 2007, 81 (8) 3969-3979 10.1128/JVI.02322-06
274. Cherepanov, P.; Devroe, E.; Silver, P. A.; Engelman, A. Identification of an Evolutionarily Conserved Domain in Human Lens Epithelium-Derived Growth Factor/Transcriptional Co-Activator p75 (LEDGF/p75) That Binds HIV-1 Integrase J. Biol. Chem. 2004, 279 (47) 48883-48892 10.1074/jbc.M406307200
275. Vanegas, M.; Llano, M.; Delgado, S.; Thompson, D.; Peretz, M.; Poeschla, E. Identification of the LEDGF/p75 HIV-1 Integrase-Interaction Domain and NLS Reveals NLS-Independent Chromatin Tethering J. Cell Sci. 2005, 118 (8) 1733-1743 10.1242/jcs.02299
276. Maertens, G.; Cherepanov, P.; Pluymers, W.; Busschots, K.; De Clercq, E.; Debyser, Z.; Engelborghs, Y. LEDGF/p75 Is Essential for Nuclear and Chromosomal Targeting of HIV-1 Integrase in Human Cells J. Biol. Chem. 2003, 278 (35) 33528-33539 10.1074/jbc.M303594200
277. Maertens, G.; Cherepanov, P.; Debyser, Z.; Engelborghs, Y.; Engelman, A. Identification and Characterization of a Functional Nuclear Localization Signal in the HIV-1 Integrase Interactor LEDGF/p75 J. Biol. Chem. 2004, 279 (32) 33421-33429 10.1074/jbc.M404700200
278. Turlure, F.; Maertens, G.; Rahman, S.; Cherepanov, P.; Engelman, A. A Tripartite DNA-Binding Element, Comprised of the Nuclear Localization Signal and Two at-Hook Motifs, Mediates the Association of LEDGF/p75 with Chromatin in Vivo Nucleic Acids Res. 2006, 34 (5) 1653-1665 10.1093/nar/gkl052
279. Llano, M.; Vanegas, M.; Hutchins, N.; Thompson, D.; Delgado, S.; Poeschla, E. M. Identification and Characterization of the Chromatin-Binding Domains of the HIV-1 Integrase Interactor LEDGF/p75 J. Mol. Biol. 2006, 360 (4) 760-773 10.1016/j.jmb.2006.04.073
280. Pradeepa, M. M.; Sutherland, H. G.; Ule, J.; Grimes, G. R.; Bickmore, W. A. Psip1/Ledgf p52 Binds Methylated Histone H3K36 and Splicing Factors and Contributes to the Regulation of Alternative Splicing PLoS Genet. 2012, 8 (5) e1002717 10.1371/journal.pgen.1002717
281. Eidahl, J. O.; Crowe, B. L.; North, J. A.; McKee, C. J.; Shkriabai, N.; Feng, L.; Plumb, M.; Graham, R. L.; Gorelick, R. J.; Hess, S. et al. Structural Basis for High-Affinity Binding of LEDGF PWWP to Mononucleosomes Nucleic Acids Res. 2013, 41 (6) 3924-3936 10.1093/nar/gkt074
282. van Nuland, R.; van Schaik, F. M.; Simonis, M.; van Heesch, S.; Cuppen, E.; Boelens, R.; Timmers, H. M.; van Ingen, H. Nucleosomal DNA Binding Drives the Recognition of H3K36-Methylated Nucleosomes by the PSIP1-PWWP Domain Epigenet. Chromatin 2013, 6 (1) 12 10.1186/1756-8935-6-12
283. Sutherland, H. G.; Newton, K.; Brownstein, D. G.; Holmes, M. C.; Kress, C.; Semple, C. A.; Bickmore, W. A. Disruption of Ledgf/Psip1 Results in Perinatal Mortality and Homeotic Skeletal Transformations Mol. Cell. Biol. 2006, 26 (19) 7201-7210 10.1128/MCB.00459-06
284. Wang, H.; Shun, M. C.; Dickson, A. K.; Engelman, A. N. Embryonic Lethality Due to Arrested Cardiac Development in Psip1/Hdgfrp2 Double-Deficient Mice PLoS One 2015, 10, e0137797 10.1371/journal.pone.0137797
285. Maertens, G. N.; Cherepanov, P.; Engelman, A. Transcriptional Co-Activator p75 Binds and Tethers the Myc-Interacting Protein JPO2 to Chromatin J. Cell Sci. 2006, 119 (12) 2563-2571 10.1242/jcs.02995
286. Bartholomeeusen, K.; De Rijck, J.; Busschots, K.; Desender, L.; Gijsbers, R.; Emiliani, S.; Benarous, R.; Debyser, Z.; Christ, F. Differential Interaction of HIV-1 Integrase and JPO2 with the C Terminus of LEDGF/p75 J. Mol. Biol. 2007, 372, 407-421 10.1016/j.jmb.2007.06.090
287. Yokoyama, A.; Cleary, M. L. Menin Critically Links MLL Proteins with LEDGF on Cancer-Associated Target Genes Cancer Cell 2008, 14 (1) 36-46 10.1016/j.ccr.2008.05.003
288. Leoh, L. S.; van Heertum, B.; De Rijck, J.; Filippova, M.; Rios-Colon, L.; Basu, A.; Martinez, S. R.; Tungteakkhun, S. S.; Filippov, V.; Christ, F. et al. The Stress Oncoprotein LEDGF/p75 Interacts with the Methyl CpG Binding Protein MeCP2 and Influences Its Transcriptional Activity Mol. Cancer Res. 2012, 10 (3) 378-391 10.1158/1541-7786.MCR-11-0314
289. Daugaard, M.; Baude, A.; Fugger, K.; Povlsen, L. K.; Beck, H.; Sorensen, C. S.; Petersen, N. H.; Sorensen, P. H.; Lukas, C.; Bartek, J. et al. LEDGF (p75) Promotes DNA-End Resection and Homologous Recombination Nat. Struct. Mol. Biol. 2012, 19 (8) 803-810 10.1038/nsmb.2314
290. Hughes, S.; Jenkins, V.; Dar, M. J.; Engelman, A.; Cherepanov, P. Transcriptional Co-Activator LEDGF Interacts with Cdc7-Activator of S-Phase Kinase (ASK) and Stimulates Its Enzymatic Activity J. Biol. Chem. 2010, 285 (1) 541-554 10.1074/jbc.M109.036491
291. van Nuland, R.; Smits, A. H.; Pallaki, P.; Jansen, P. W.; Vermeulen, M.; Timmers, H. T. Quantitative Dissection and Stoichiometry Determination of the Human SET1/MLL Histone Methyltransferase Complexes Mol. Cell. Biol. 2013, 33 (10) 2067-2077 10.1128/MCB.01742-12
292. Vandekerckhove, L.; Christ, F.; Van Maele, B.; De Rijck, J.; Gijsbers, R.; Van den Haute, C.; Witvrouw, M.; Debyser, Z. Transient and Stable Knockdown of the Integrase Cofactor LEDGF/p75 Reveals Its Role in the Replication Cycle of Human Immunodeficiency Virus J. Virol. 2006, 80 (4) 1886-1896 10.1128/JVI.80.4.1886-1896.2006
293. Zielske, S. P.; Stevenson, M. Modest but Reproducible Inhibition of Human Immunodeficiency Virus Type 1 Infection in Macrophages Following LEDGFp75 Silencing J. Virol. 2006, 80 (14) 7275-7280 10.1128/JVI.02470-05
294. Vandegraaff, N.; Devroe, E.; Turlure, F.; Silver, P. A.; Engelman, A. Biochemical and Genetic Analyses of Integrase-Interacting Proteins Lens Epithelium-Derived Growth Factor (LEDGF)/p75 and Hepatoma-Derived Growth Factor Related Protein 2 (HRP2) in Preintegration Complex Function and HIV-1 Replication Virology 2006, 346, 415-426 10.1016/j.virol.2005.11.022
295. Llano, M.; Saenz, D. T.; Meehan, A.; Wongthida, P.; Peretz, M.; Walker, W. H.; Teo, W.; Poeschla, E. M. An Essential Role for LEDGF/p75 in HIV Integration Science 2006, 314 (5798) 461-464 10.1126/science.1132319
296. Marshall, H. M.; Ronen, K.; Berry, C.; Llano, M.; Sutherland, H.; Saenz, D.; Bickmore, W.; Poeschla, E.; Bushman, F. D. Role of PSIP1/LEDGF/p75 in Lentiviral Infectivity and Integration Targeting PLoS One 2007, 2 (12) e1340 10.1371/journal.pone.0001340
297. Fadel, H. J.; Morrison, J. H.; Saenz, D. T.; Fuchs, J. R.; Kvaratskhelia, M.; Ekker, S. C.; Poeschla, E. M. TALEN Knockout of the PSIP1 Gene in Human Cells: Analyses of HIV-1 Replication and Allosteric Integrase Inhibitor Mechanism J. Virol. 2014, 88 (17) 9704-9717 10.1128/JVI.01397-14
298. Schrijvers, R.; De Rijck, J.; Demeulemeester, J.; Adachi, N.; Vets, S.; Ronen, K.; Christ, F.; Bushman, F. D.; Debyser, Z.; Gijsbers, R. LEDGF/p75-Independent HIV-1 Replication Demonstrates a Role for HRP-2 and Remains Sensitive to Inhibition by LEDGINs PLoS Pathog. 2012, 8 (3) e1002558 10.1371/journal.ppat.1002558
299. Shun, M. C.; Raghavendra, N. K.; Vandegraaff, N.; Daigle, J. E.; Hughes, S.; Kellam, P.; Cherepanov, P.; Engelman, A. LEDGF/p75 Functions Downstream from Preintegration Complex Formation to Effect Gene-Specific HIV-1 Integration Genes Dev. 2007, 21 (14) 1767-1778 10.1101/gad.1565107
300. Ciuffi, A.; Llano, M.; Poeschla, E.; Hoffmann, C.; Leipzig, J.; Shinn, P.; Ecker, J. R.; Bushman, F. A Role for LEDGF/p75 in Targeting HIV DNA Integration Nat. Med. 2005, 11 (12) 1287-1289 10.1038/nm1329
301. Ferris, A. L.; Wu, X.; Hughes, C. M.; Stewart, C.; Smith, S. J.; Milne, T. A.; Wang, G. G.; Shun, M. C.; Allis, C. D.; Engelman, A. et al. Lens Epithelium-Derived Growth Factor Fusion Proteins Redirect HIV-1 DNA Integration Proc. Natl. Acad. Sci. U. S. A. 2010, 107 (7) 3135-3140 10.1073/pnas.0914142107
302. Gijsbers, R.; Ronen, K.; Vets, S.; Malani, N.; De Rijck, J.; McNeely, M.; Bushman, F. D.; Debyser, Z. LEDGF Hybrids Efficiently Retarget Lentiviral Integration into Heterochromatin Mol. Ther. 2010, 18 (3) 552-560 10.1038/mt.2010.36
303. Silvers, R. M.; Smith, J. A.; Schowalter, M.; Litwin, S.; Liang, Z.; Geary, K.; Daniel, R. Modification of Integration Site Preferences of an HIV-1-Based Vector by Expression of a Novel Synthetic Protein Hum. Gene Ther. 2010, 21 (3) 337-349 10.1089/hum.2009.134
304. Dahabieh, M. S.; Ooms, M.; Simon, V.; Sadowski, I. A Doubly Fluorescent HIV-1 Reporter Shows That the Majority of Integrated HIV-1 Is Latent Shortly after Infection J. Virol. 2013, 87 (8) 4716-4727 10.1128/JVI.03478-12
305. Jeeninga, R. E.; Westerhout, E. M.; van Gerven, M. L.; Berkhout, B. HIV-1 Latency in Actively Dividing Human T Cell Lines Retrovirology 2008, 5, 37 10.1186/1742-4690-5-37
306. Duverger, A.; Jones, J.; May, J.; Bibollet-Ruche, F.; Wagner, F. A.; Cron, R. Q.; Kutsch, O. Determinants of the Establishment of Human Immunodeficiency Virus Type 1 Latency J. Virol. 2009, 83 (7) 3078-3093 10.1128/JVI.02058-08
307. Cherepanov, P.; Sun, Z. Y.; Rahman, S.; Maertens, G.; Wagner, G.; Engelman, A. Solution Structure of the HIV-1 Integrase-Binding Domain in LEDGF/p75 Nat. Struct. Mol. Biol. 2005, 12 (6) 526-532 10.1038/nsmb937
308. Cherepanov, P.; Ambrosio, A. L.; Rahman, S.; Ellenberger, T.; Engelman, A. Structural Basis for the Recognition between HIV-1 Integrase and Transcriptional Coactivator p75 Proc. Natl. Acad. Sci. U. S. A. 2005, 102, 17308 10.1073/pnas.0506924102
309. McKee, C. J.; Kessl, J. J.; Shkriabai, N.; Dar, M. J.; Engelman, A.; Kvaratskhelia, M. Dynamic Modulation of HIV-1 Integrase Structure and Function by Cellular Lens Epithelium-Derived Growth Factor (LEDGF) Protein J. Biol. Chem. 2008, 283 (46) 31802-31812 10.1074/jbc.M805843200
310. Tsiang, M.; Jones, G. S.; Niedziela-Majka, A.; Kan, E.; Lansdon, E. B.; Huang, W.; Hung, M.; Samuel, D.; Novikov, N.; Xu, Y. et al. New Class of HIV-1 Integrase (IN) Inhibitors with a Dual Mode of Action J. Biol. Chem. 2012, 287 (25) 21189-21203 10.1074/jbc.M112.347534
311. Kessl, J. J.; Jena, N.; Koh, Y.; Taskent-Sezgin, H.; Slaughter, A.; Feng, L.; de Silva, S.; Wu, L.; Le Grice, S. F.; Engelman, A. et al. Multimode, Cooperative Mechanism of Action of Allosteric HIV-1 Integrase Inhibitors J. Biol. Chem. 2012, 287 (20) 16801-16811 10.1074/jbc.M112.354373
312. Christ, F.; Voet, A.; Marchand, A.; Nicolet, S.; Desimmie, B. A.; Marchand, D.; Bardiot, D.; Van der Veken, N. J.; Van Remoortel, B.; Strelkov, S. V.; Debyser, Z. et al. Rational Design of Small-Molecule Inhibitors of the LEDGF/p75-Integrase Interaction and HIV Replication Nat. Chem. Biol. 2010, 6 (6) 442-448 10.1038/nchembio.370
313. Fader, L. D.; Malenfant, E.; Parisien, M.; Carson, R.; Bilodeau, F.; Landry, S.; Pesant, M.; Brochu, C.; Morin, S.; Chabot, C. et al. Discovery of BI 224436, a Noncatalytic Site Integrase Inhibitor (NCINI) of HIV-1 ACS Med. Chem. Lett. 2014, 5, 422-427 10.1021/ml500002n
314. Gupta, K.; Brady, T.; Dyer, B. M.; Malani, N.; Hwang, Y.; Male, F.; Nolte, R. T.; Wang, L.; Velthuisen, E.; Jeffrey, J. et al. Allosteric Inhibition of Human Immunodeficiency Virus Integrase: Late Block During Viral Replication and Abnormal Multimerization Involving Specific Protein Domains J. Biol. Chem. 2014, 289 (30) 20477-20488 10.1074/jbc.M114.551119
315. Sharma, A.; Slaughter, A.; Jena, N.; Feng, L.; Kessl, J. J.; Fadel, H. J.; Malani, N.; Male, F.; Wu, L.; Poeschla, E. et al. A New Class of Multimerization Selective Inhibitors of HIV-1 Integrase PLoS Pathog. 2014, 10 (5) e1004171 10.1371/journal.ppat.1004171
316. Christ, F.; Shaw, S.; Demeulemeester, J.; Desimmie, B. A.; Marchand, A.; Butler, S.; Smets, W.; Chaltin, P.; Westby, M.; Debyser, Z. et al. Small-Molecule Inhibitors of the LEDGF/p75 Binding Site of Integrase Block HIV Replication and Modulate Integrase Multimerization Antimicrob. Agents Chemother. 2012, 56 (8) 4365-4374 10.1128/AAC.00717-12
317. Le Rouzic, E.; Bonnard, D.; Chasset, S.; Bruneau, J. M.; Chevreuil, F.; Le Strat, F.; Nguyen, J.; Beauvoir, R.; Amadori, C.; Brias, J. et al. Dual Inhibition of HIV-1 Replication by Integrase-LEDGF Allosteric Inhibitors Is Predominant at the Post-Integration Stage Retrovirology 2013, 10, 144 10.1186/1742-4690-10-144
318. Shkriabai, N.; Dharmarajan, V.; Slaughter, A.; Kessl, J. J.; Larue, R. C.; Feng, L.; Fuchs, J. R.; Griffin, P. R.; Kvaratskhelia, M. A Critical Role of the C-Terminal Segment for Allosteric Inhibitor-Induced Aberrant Multimerization of HIV-1 Integrase J. Biol. Chem. 2014, 289 (38) 26430-26440 10.1074/jbc.M114.589572
319. Sharma, A.; Larue, R. C.; Plumb, M. R.; Malani, N.; Male, F.; Slaughter, A.; Kessl, J. J.; Shkriabai, N.; Coward, E.; Aiyer, S. S. et al. BET Proteins Promote Efficient Murine Leukemia Virus Integration at Transcription Start Sites Proc. Natl. Acad. Sci. U. S. A. 2013, 110 (29) 12036-12041 10.1073/pnas.1307157110
320. Gupta, S. S.; Maetzig, T.; Maertens, G. N.; Sharif, A.; Rothe, M.; Weidner-Glunde, M.; Galla, M.; Schambach, A.; Cherepanov, P.; Schulz, T. F. Bromo- and Extraterminal Domain Chromatin Regulators Serve as Cofactors for Murine Leukemia Virus Integration J. Virol. 2013, 87 (23) 12721-12736 10.1128/JVI.01942-13
321. De Rijck, J.; de Kogel, C.; Demeulemeester, J.; Vets, S.; El Ashkar, S.; Malani, N.; Bushman, F. D.; Landuyt, B.; Husson, S. J.; Busschots, K. et al. The BET Family of Proteins Targets Moloney Murine Leukemia Virus Integration near Transcription Start Sites Cell Rep. 2013, 5 (4) 886-894 10.1016/j.celrep.2013.09.040
322. Wu, S. Y.; Chiang, C. M. The Double Bromodomain-Containing Chromatin Adaptor Brd4 and Transcriptional Regulation J. Biol. Chem. 2007, 282 (18) 13141-13145 10.1074/jbc.R700001200
323. Belkina, A. C.; Denis, G. V. BET Domain Co-Regulators in Obesity, Inflammation and Cancer Nat. Rev. Cancer 2012, 12 (7) 465-477 10.1038/nrc3256
324. Weidner-Glunde, M.; Ottinger, M.; Schulz, T. F. What Do Viruses BET On? Front. Biosci., Landmark Ed. 2010, 15, 537-549 10.2741/3632
325. Zhu, J.; Gaiha, G. D.; John, S. P.; Pertel, T.; Chin, C. R.; Gao, G.; Qu, H.; Walker, B. D.; Elledge, S. J.; Brass, A. L. Reactivation of Latent HIV-1 by Inhibition of Brd4 Cell Rep. 2012, 2 (4) 807-816 10.1016/j.celrep.2012.09.008
326. You, J.; Croyle, J. L.; Nishimura, A.; Ozato, K.; Howley, P. M. Interaction of the Bovine Papillomavirus E2 Protein with Brd4 Tethers the Viral DNA to Host Mitotic Chromosomes Cell 2004, 117 (3) 349-360 10.1016/S0092-8674(04)00402-7
327. Dey, A.; Chitsaz, F.; Abbasi, A.; Misteli, T.; Ozato, K. The Double Bromodomain Protein Brd4 Binds to Acetylated Chromatin During Interphase and Mitosis Proc. Natl. Acad. Sci. U. S. A. 2003, 100 (15) 8758-8763 10.1073/pnas.1433065100
328. Jang, M. K.; Mochizuki, K.; Zhou, M.; Jeong, H. S.; Brady, J. N.; Ozato, K. The Bromodomain Protein Brd4 Is a Positive Regulatory Component of P-TEFb and Stimulates RNA Polymerase II-Dependent Transcription Mol. Cell 2005, 19 (4) 523-534 10.1016/j.molcel.2005.06.027
329. Baxter, M. K.; McPhillips, M. G.; Ozato, K.; McBride, A. A. The Mitotic Chromosome Binding Activity of the Papillomavirus E2 Protein Correlates with Interaction with the Cellular Chromosomal Protein, Brd4 J. Virol. 2005, 79 (8) 4806-4818 10.1128/JVI.79.8.4806-4818.2005
330. You, J.; Srinivasan, V.; Denis, G. V.; Harrington, W. J., Jr.; Ballestas, M. E.; Kaye, K. M.; Howley, P. M. Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Interacts with Bromodomain Protein Brd4 on Host Mitotic Chromosomes J. Virol. 2006, 80 (18) 8909-8919 10.1128/JVI.00502-06
331. Ottinger, M.; Christalla, T.; Nathan, K.; Brinkmann, M. M.; Viejo-Borbolla, A.; Schulz, T. F. Kaposi's Sarcoma-Associated Herpesvirus LANA-1 Interacts with the Short Variant of BRD4 and Releases Cells from a BRD4- and BRD2/RING3-Induced G1 Cell Cycle Arrest J. Virol. 2006, 80 (21) 10772-10786 10.1128/JVI.00804-06
332. LeRoy, G.; Chepelev, I.; DiMaggio, P. A.; Blanco, M. A.; Zee, B. M.; Zhao, K.; Garcia, B. A. Proteogenomic Characterization and Mapping of Nucleosomes Decoded by Brd and HP1 Proteins Genome Biol. 2012, 13 (8) R68 10.1186/gb-2012-13-8-r68
333. Larue, R. C.; Plumb, M. R.; Crowe, B. L.; Shkriabai, N.; Sharma, A.; DiFiore, J.; Malani, N.; Aiyer, S. S.; Roth, M. J.; Bushman, F. D. et al. Bimodal High-Affinity Association of Brd4 with Murine Leukemia Virus Integrase and Mononucleosomes Nucleic Acids Res. 2014, 42 (8) 4868-4881 10.1093/nar/gku135
334. Aiyer, S.; Swapna, G. V.; Malani, N.; Aramini, J. M.; Schneider, W. M.; Plumb, M. R.; Ghanem, M.; Larue, R. C.; Sharma, A.; Studamire, B. et al. Altering Murine Leukemia Virus Integration through Disruption of the Integrase and BET Protein Family Interaction Nucleic Acids Res. 2014, 42 (9) 5917-5928 10.1093/nar/gku175
335. Crowe, B. L.; Larue, R. C.; Yuan, C.; Hess, S.; Kvaratskhelia, M.; Foster, M. P. Structure of the Brd4 ET Domain Bound to a C-Terminal Motif from Gamma-Retroviral Integrases Reveals a Conserved Mechanism of Interaction Proc. Natl. Acad. Sci. U. S. A. 2016, 113 (8) 2086-2091 10.1073/pnas.1516813113
336. El Ashkar, S.; De Rijck, J.; Demeulemeester, J.; Vets, S.; Madlala, P.; Cermakova, K.; Debyser, Z.; Gijsbers, R. BET-Independent MLV-Based Vectors Target Away from Promoters and Regulatory Elements Mol. Ther. - Nucleic Acids 2014, 3, e179 10.1038/mtna.2014.33
337. Maertens, G. N. B′-Protein Phosphatase 2A Is a Functional Binding Partner of Delta-Retroviral Integrase Nucleic Acids Res. 2016, 44 (1) 364-376 10.1093/nar/gkv1347
338. Eichhorn, P. J.; Creyghton, M. P.; Bernards, R. Protein Phosphatase 2A Regulatory Subunits and Cancer Biochim. Biophys. Acta, Rev. Cancer 2009, 1795 (1) 1-15 10.1016/j.bbcan.2008.05.005
339. Shanker, V.; Trincucci, G.; Heim, H. M.; Duong, H. T. Protein Phosphatase 2A Impairs IFNalpha-Induced Antiviral Activity against the Hepatitis C Virus through the Inhibition of STAT1 Tyrosine Phosphorylation J. Viral. Hepat. 2013, 20 (9) 612-621 10.1111/jvh.12083
340. Curcio, M. J.; Lutz, S.; Lesage, P. The Ty1 LTR-Retrotransposon of Budding Yeast, Saccharomyces Cerevisiae Microbiol. Spectr. 2015, 3 (2) MDNA3-0053-2014 10.1128/microbiolspec.MDNA3-0053-2014
341. Zhu, Y.; Dai, J.; Fuerst, P. G.; Voytas, D. F. Controlling Integration Specificity of a Yeast Retrotransposon Proc. Natl. Acad. Sci. U. S. A. 2003, 100 (10) 5891-5895 10.1073/pnas.1036705100
342. Brady, T. L.; Fuerst, P. G.; Dick, R. A.; Schmidt, C.; Voytas, D. F. Retrotransposon Target Site Selection by Imitation of a Cellular Protein Mol. Cell. Biol. 2008, 28 (4) 1230-1239 10.1128/MCB.01502-07
343. Xie, W.; Gai, X.; Zhu, Y.; Zappulla, D. C.; Sternglanz, R.; Voytas, D. F. Targeting of the Yeast Ty5 Retrotransposon to Silent Chromatin Is Mediated by Interactions between Integrase and Sir4p Mol. Cell. Biol. 2001, 21 (19) 6606-6614 10.1128/MCB.21.19.6606-6614.2001
344. Bridier-Nahmias, A.; Tchalikian-Cosson, A.; Baller, J. A.; Menouni, R.; Fayol, H.; Flores, A.; Saib, A.; Werner, M.; Voytas, D. F.; Lesage, P. Retrotransposons. An RNA Polymerase III Subunit Determines Sites of Retrotransposon Integration Science 2015, 348 (6234) 585-588 10.1126/science.1259114
345. Hazuda, D. J.; Felock, P.; Witmer, M.; Wolfe, A.; Stillmock, K.; Grobler, J. A.; Espeseth, A.; Gabryelski, L.; Schleif, W.; Blau, C. et al. Inhibitors of Strand Transfer That Prevent Integration and Inhibit HIV- 1 Replication in Cells Science 2000, 287 (5453) 646-650 10.1126/science.287.5453.646
346. Hazuda, D. J.; Hastings, J. C.; Wolfe, A. L.; Emini, E. A. A Novel Assay for the DNA Strand-Transfer Reaction of HIV-1 Integrase Nucleic Acids Res. 1994, 22 (6) 1121-1122 10.1093/nar/22.6.1121
347. Murray, J. M.; Emery, S.; Kelleher, A. D.; Law, M.; Chen, J.; Hazuda, D. J.; Nguyen, B. Y.; Teppler, H.; Cooper, D. A. Antiretroviral Therapy with the Integrase Inhibitor Raltegravir Alters Decay Kinetics of HIV, Significantly Reducing the Second Phase AIDS 2007, 21 (17) 2315-2321 10.1097/QAD.0b013e3282f12377
348. Summa, V.; Petrocchi, A.; Bonelli, F.; Crescenzi, B.; Donghi, M.; Ferrara, M.; Fiore, F.; Gardelli, C.; Gonzalez Paz, O.; Hazuda, D. J. et al. Discovery of Raltegravir, a Potent, Selective Orally Bioavailable HIV-Integrase Inhibitor for the Treatment of HIV-AIDS Infection J. Med. Chem. 2008, 51 (18) 5843-5855 10.1021/jm800245z
349. Sato, M.; Motomura, T.; Aramaki, H.; Matsuda, T.; Yamashita, M.; Ito, Y.; Kawakami, H.; Matsuzaki, Y.; Watanabe, W.; Yamataka, K. et al. Novel HIV-1 Integrase Inhibitors Derived from Quinolone Antibiotics J. Med. Chem. 2006, 49 (5) 1506-1508 10.1021/jm0600139
350. Johns, B. A.; Kawasuji, T.; Weatherhead, J. G.; Taishi, T.; Temelkoff, D. P.; Yoshida, H.; Akiyama, T.; Taoda, Y.; Murai, H.; Kiyama, R. et al. Carbamoyl Pyridone HIV-1 Integrase Inhibitors 3. A Diastereomeric Approach to Chiral Nonracemic Tricyclic Ring Systems and the Discovery of Dolutegravir (S/GSK1349572) and (S/GSK1265744) J. Med. Chem. 2013, 56 (14) 5901-5916 10.1021/jm400645w
351. Bar-Magen, T.; Sloan, R. D.; Faltenbacher, V. H.; Donahue, D. A.; Kuhl, B. D.; Oliveira, M.; Xu, H.; Wainberg, M. A. Comparative Biochemical Analysis of HIV-1 Subtype B and C Integrase Enzymes Retrovirology 2009, 6, 103 10.1186/1742-4690-6-103
352. Hightower, K. E.; Wang, R.; Deanda, F.; Johns, B. A.; Weaver, K.; Shen, Y.; Tomberlin, G. H.; Carter, H. L., 3rd; Broderick, T.; Sigethy, S. et al. Dolutegravir (S/GSK1349572) Exhibits Significantly Slower Dissociation Than Raltegravir and Elvitegravir from Wild-Type and Integrase Inhibitor-Resistant HIV-1 Integrase-DNA Complexes Antimicrob. Agents Chemother. 2011, 55 (10) 4552-4559 10.1128/AAC.00157-11
353. Grobler, J.; Stillmock, K.; Miller, D. G.; Hazuda, D. Mechanism by Which the HIV Integrase Active-Site Mutation N155H Confers Resistance to Raltegravir Antiviral Ther 2008, 13, A41
354. Lewis, M. G.; Norelli, S.; Collins, M.; Barreca, M. L.; Iraci, N.; Chirullo, B.; Yalley-Ogunro, J.; Greenhouse, J.; Titti, F.; Garaci, E. et al. Response of a Simian Immunodeficiency Virus (SIVmac251) to Raltegravir: A Basis for a New Treatment for Simian AIDS and an Animal Model for Studying Lentiviral Persistence During Antiretroviral Therapy Retrovirology 2010, 7, 21 10.1186/1742-4690-7-21
355. Koh, Y.; Matreyek, K. A.; Engelman, A. Differential Sensitivities of Retroviruses to Integrase Strand Transfer Inhibitors J. Virol. 2011, 85 (7) 3677-3682 10.1128/JVI.02541-10
356. Hare, S.; Smith, S. J.; Metifiot, M.; Jaxa-Chamiec, A.; Pommier, Y.; Hughes, S. H.; Cherepanov, P. Structural and Functional Analyses of the Second-Generation Integrase Strand Transfer Inhibitor Dolutegravir (S/GSK1349572) Mol. Pharmacol. 2011, 80, 565 10.1124/mol.111.073189
357. Langley, D. R.; Samanta, H. K.; Lin, Z.; Walker, M. A.; Krystal, M. R.; Dicker, I. B. The Terminal (Catalytic) Adenosine of the HIV LTR Controls the Kinetics of Binding and Dissociation of HIV Integrase Strand Transfer Inhibitors Biochemistry 2008, 47 (51) 13481-13488 10.1021/bi801372d
358. Zhao, X. Z.; Smith, S. J.; Maskell, D. P.; Metifiot, M.; Pye, V. E.; Fesen, K.; Marchand, C.; Pommier, Y.; Cherepanov, P.; Hughes, S. H. et al. HIV-1 Integrase Strand Transfer Inhibitors with Reduced Susceptibility to Drug Resistant Mutant Integrases ACS Chem. Biol. 2016, 11, 1074 10.1021/acschembio.5b00948
359. Grobler, J. A.; Hazuda, D. J. Resistance to HIV Integrase Strand Transfer Inhibitors: In Vitro Findings and Clinical Consequences Curr. Opin. Virol. 2014, 8, 98-103 10.1016/j.coviro.2014.07.006
360. Mesplede, T.; Wainberg, M. A. Resistance against Integrase Strand Transfer Inhibitors and Relevance to HIV Persistence Viruses 2015, 7 (7) 3703-3718 10.3390/v7072790
361. Canducci, F.; Ceresola, E. R.; Boeri, E.; Spagnuolo, V.; Cossarini, F.; Castagna, A.; Lazzarin, A.; Clementi, M. Cross-Resistance Profile of the Novel Integrase Inhibitor Dolutegravir (S/GSK1349572) Using Clonal Viral Variants Selected in Patients Failing Raltegravir J. Infect. Dis. 2011, 204 (11) 1811-1815 10.1093/infdis/jir636
362. Goethals, O.; Vos, A.; Van Ginderen, M.; Geluykens, P.; Smits, V.; Schols, D.; Hertogs, K.; Clayton, R. Primary Mutations Selected in Vitro with Raltegravir Confer Large Fold Changes in Susceptibility to First-Generation Integrase Inhibitors, but Minor Fold Changes to Inhibitors with Second-Generation Resistance Profiles Virology 2010, 402 (2) 338-346 10.1016/j.virol.2010.03.034
363. Naeger, L. K.; Harrington, P.; Komatsu, T.; Deming, D. Effect of Dolutegravir Functional Monotherapy on HIV-1 Virological Response in Integrase Strand Transfer Inhibitor Resistant Patients Antiviral Ther. 2016, 10.3851/IMP3033
364. Cooper, D. A.; Steigbigel, R. T.; Gatell, J. M.; Rockstroh, J. K.; Katlama, C.; Yeni, P.; Lazzarin, A.; Clotet, B.; Kumar, P. N.; Eron, J. E. et al. Subgroup and Resistance Analyses of Raltegravir for Resistant HIV-1 Infection N. Engl. J. Med. 2008, 359 (4) 355-365 10.1056/NEJMoa0708978
365. Raheem, I. T.; Walji, A. M.; Klein, D.; Sanders, J. M.; Powell, D. A.; Abeywickrema, P.; Barbe, G.; Bennet, A.; Clas, S. D.; Dubost, D. et al. Discovery of 2-Pyridinone Aminals: A Prodrug Strategy to Advance a Second Generation of HIV-1 Integrase Strand Transfer Inhibitors J. Med. Chem. 2015, 58 (20) 8154-8165 10.1021/acs.jmedchem.5b01037
366. Jurado, K. A.; Engelman, A. Multimodal Mechanism of Action of Allosteric HIV-1 Integrase Inhibitors Expert Rev. Mol. Med. 2013, 15, e14 10.1017/erm.2013.15
367. Engelman, A.; Kessl, J. J.; Kvaratskhelia, M. Allosteric Inhibition of HIV-1 Integrase Activity Curr. Opin. Chem. Biol. 2013, 17 (3) 339-345 10.1016/j.cbpa.2013.04.010
368. Molteni, V.; Greenwald, J.; Rhodes, D.; Hwang, Y.; Kwiatkowski, W.; Bushman, F. D.; Siegel, J. S.; Choe, S. Identification of a Small-Molecule Binding Site at the Dimer Interface of the HIV Integrase Catalytic Domain Acta Crystallogr., Sect. D: Biol. Crystallogr. 2001, 57, 536-544 10.1107/S0907444901001652
369. De Rijck, J.; Vandekerckhove, L.; Gijsbers, R.; Hombrouck, A.; Hendrix, J.; Vercammen, J.; Engelborghs, Y.; Christ, F.; Debyser, Z. Overexpression of the Lens Epithelium-Derived Growth Factor/p75 Integrase Binding Domain Inhibits Human Immunodeficiency Virus Replication J. Virol. 2006, 80 (23) 11498-11509 10.1128/JVI.00801-06
370. Meehan, A. M.; Saenz, D. T.; Morrison, J.; Hu, C.; Peretz, M.; Poeschla, E. M. LEDGF Dominant Interference Proteins Demonstrate Prenuclear Exposure of HIV-1 Integrase and Synergize with LEDGF Depletion to Destroy Viral Infectivity J. Virol. 2011, 85 (7) 3570-3583 10.1128/JVI.01295-10
371. Tsantrizos, Y. S.; Boes, M.; Brochu, C.; Fenwick, C.; Malenfant, E.; Mason, S.; Pesant, M. Inhibitors of Human Immunodeficiency Virus Replication. Patent WO/2007/131350, 2007.
372. Desimmie, B. A.; Schrijvers, R.; Demeulemeester, J.; Borrenberghs, D.; Weydert, C.; Thys, W.; Vets, S.; Van Remoortel, B.; Hofkens, J.; De Rijck, J. et al. LEDGINs Inhibit Late Stage HIV-1 Replication by Modulating Integrase Multimerization in the Virions Retrovirology 2013, 10, 57 10.1186/1742-4690-10-57
373. van Bel, N.; van der Velden, Y.; Bonnard, D.; Le Rouzic, E.; Das, A. T.; Benarous, R.; Berkhout, B. The Allosteric HIV-1 Integrase Inhibitor BI-D Affects Virion Maturation but Does Not Influence Packaging of a Functional RNA Genome PLoS One 2014, 9, e103552 10.1371/journal.pone.0103552
374. Wang, H.; Jurado, K. A.; Wu, X.; Shun, M. C.; Li, X.; Ferris, A. L.; Smith, S. J.; Patel, P. A.; Fuchs, J. R.; Cherepanov, P. et al. HRP2 Determines the Efficiency and Specificity of HIV-1 Integration in LEDGF/p75 Knockout Cells but Does Not Contribute to the Antiviral Activity of a Potent LEDGF/p75-Binding Site Integrase Inhibitor Nucleic Acids Res. 2012, 40 (22) 11518-11530 10.1093/nar/gks913
375. Fenwick, C.; Amad, M.; Bailey, M. D.; Bethell, R.; Bös, M.; Bonneau, P.; Cordingley, M.; Coulombe, R.; Duan, J.; Edwards, P. et al. Preclinical Profile of BI 224436, a Novel HIV-1 Non-Catalytic-Site Integrase Inhibitor Antimicrob. Agents Chemother. 2014, 58, 3233-3244 10.1128/AAC.02719-13
376. Naldini, L. Gene Therapy Returns to Centre Stage Nature 2015, 526, 351-360 10.1038/nature15818
377. Cavazzana-Calvo, M.; Hacein-Bey, S.; de Saint Basile, G.; Gross, F.; Yvon, E.; Nusbaum, P.; Selz, F.; Hue, C.; Certain, S.; Casanova, J. L. et al. Gene Therapy of Human Severe Combined Immunodeficiency (SCID)-X1 Disease Science 2000, 288 (5466) 669-672
378. Braun, C. J.; Boztug, K.; Paruzynski, A.; Witzel, M.; Schwarzer, A.; Rothe, M.; Modlich, U.; Beier, R.; Göhring, G.; Steinemann, D. et al. Gene Therapy for Wiskott-Aldrich Syndrome - Long-Term Efficacy and Genotoxicity Sci. Transl. Med. 2014, 6, 227ra33 10.1126/scitranslmed.3007280
379. Ott, M. G.; Schmidt, M.; Schwarzwaelder, K.; Stein, S.; Siler, U.; Koehl, U.; Glimm, H.; Kuhlcke, K.; Schilz, A.; Kunkel, H. et al. Correction of X-Linked Chronic Granulomatous Disease by Gene Therapy, Augmented by Insertional Activation of MDS1-EVI1, PRMD16 or SETBP1 Nat. Med. 2006, 12 (4) 401-409 10.1038/nm1393
380. Kohn, D. B. Update on Gene Therapy for Immunodeficiencies Clin. Immunol. 2010, 135 (2) 247-254 10.1016/j.clim.2009.12.003
381. Hacein-Bey-Abina, S.; von Kalle, C.; Schmidt, M.; Le Deist, F.; Wulffraat, N.; McIntyre, E.; Radford, I.; Villeval, J. L.; Fraser, C. C.; Cavazzana-Calvo, M. et al. A Serious Adverse Event after Successful Gene Therapy for X-Linked Severe Combined Immunodeficiency N. Engl. J. Med. 2003, 348 (3) 255-256 10.1056/NEJM200301163480314
382. Hacein-Bey-Abina, S.; Garrigue, A.; Wang, G. P.; Soulier, J.; Lim, A.; Morillon, E.; Clappier, E.; Caccavelli, L.; Delabesse, E.; Beldjord, K. et al. Insertional Oncogenesis in 4 Patients after Retrovirus-Mediated Gene Therapy of SCID-X1 J. Clin. Invest. 2008, 118, 3132-3142 10.1172/JCI35700
383. Howe, S. J.; Mansour, M. R.; Schwarzwaelder, K.; Bartholomae, C.; Hubank, M.; Kempski, H.; Brugman, M. H.; Pike-Overzet, K.; Chatters, S. J.; de Ridder, D. et al. Insertional Mutagenesis Combined with Acquired Somatic Mutations Causes Leukemogenesis Following Gene Therapy of SCID-X1 Patients J. Clin. Invest. 2008, 118, 3143-3150 10.1172/JCI35798
384. Hacein-Bey-Abina, S.; Von Kalle, C.; Schmidt, M.; McCormack, M. P.; Wulffraat, N.; Leboulch, P.; Lim, A.; Osborne, C. S.; Pawliuk, R.; Morillon, E. et al. LMO2-Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1 Science 2003, 302 (5644) 415-419 10.1126/science.1088547
385. Kung, H. J.; Boerkoel, C.; Carter, T. H. Retroviral Mutagenesis of Cellular Oncogenes: A Review with Insights into the Mechanisms of Insertional Activation Curr. Top. Microbiol. Immunol. 1991, 171, 1-25 10.1007/978-3-642-76524-7-1
386. Suerth, J. D.; Labenski, V.; Schambach, A. Alpharetroviral Vectors: From a Cancer-Causing Agent to a Useful Tool for Human Gene Therapy Viruses 2014, 6 (12) 4811-4838 10.3390/v6124811
387. Konstantoulas, C. J.; Indik, S. Mouse Mammary Tumor Virus-Based Vector Transduces Non-Dividing Cells, Enters the Nucleus Via a TNPO3-Independent Pathway and Integrates in a Less Biased Fashion Than Other Retroviruses Retrovirology 2014, 11, 34 10.1186/1742-4690-11-34
388. Olszko, M. E.; Trobridge, G. D. Foamy Virus Vectors for HIV Gene Therapy Viruses 2013, 5, 2585-2600 10.3390/v5102585
389. Roth, M. J. Mutational Analysis of the Carboxyl Terminus of the Moloney Murine Leukemia Virus Integration Protein J. Virol. 1991, 65, 2141-2145
390. Yu, S. F.; von Rüden, T.; Kantoff, P. W.; Garber, C.; Seiberg, M.; Rüther, U.; Anderson, W. F.; Wagner, E. F.; Gilboa, E. Self-Inactivating Retroviral Vectors Designed for Transfer of Whole Genes into Mammalian Cells Proc. Natl. Acad. Sci. U. S. A. 1986, 83, 3194-3198 10.1073/pnas.83.10.3194
391. Hacein-Bey-Abina, S.; Pai, S.-Y.; Gaspar, H. B.; Armant, M.; Berry, C. C.; Blanche, S.; Bleesing, J.; Blondeau, J.; de Boer, H.; Buckland, K. F. et al. A Modified Gammaretrovirus Vector for X-Linked Severe Combined Immunodeficiency N. Engl. J. Med. 2014, 371 (15) 1407-1417 10.1056/NEJMoa1404588
392. Perelson, A. S.; Neumann, A. U.; Markowitz, M.; Leonard, J. M.; Ho, D. D. HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation Time Science 1996, 271, 1582-1586 10.1126/science.271.5255.1582
393. Cao, J.; Park, I. W.; Cooper, A.; Sodroski, J. Molecular Determinants of Acute Single-Cell Lysis by Human Immunodeficiency Virus Type 1 J. Virol. 1996, 70 (3) 1340-1354
394. Somasundaran, M.; Sharkey, M.; Brichacek, B.; Luzuriaga, K.; Emerman, M.; Sullivan, J. L.; Stevenson, M. Evidence for a Cytopathogenicity Determinant in HIV-1 Vpr Proc. Natl. Acad. Sci. U. S. A. 2002, 99 (14) 9503-9508 10.1073/pnas.142313699
395. Cartier, N.; Hacein-Bey-Abina, S.; Bartholomae, C. C.; Veres, G.; Schmidt, M.; Kutschera, I.; Vidaud, M.; Abel, U.; Dal-Cortivo, L.; Caccavelli, L. et al. Hematopoietic Stem Cell Gene Therapy with a Lentiviral Vector in X-Linked Adrenoleukodystrophy Science 2009, 326, 818-823 10.1126/science.1171242
396. Aiuti, A.; Biasco, L.; Scaramuzza, S.; Ferrua, F.; Cicalese, M. P.; Baricordi, C.; Dionisio, F.; Calabria, A.; Giannelli, S.; Castiello, M. C. et al. Lentiviral Hematopoietic Stem Cell Gene Therapy in Patients with Wiskott-Aldrich Syndrome Science 2013, 341 (6148) 1233151 10.1126/science.1233151
397. Biffi, A.; Montini, E.; Lorioli, L.; Cesani, M.; Fumagalli, F.; Plati, T.; Baldoli, C.; Martino, S.; Calabria, A.; Canale, S. et al. Lentiviral Hematopoietic Stem Cell Gene Therapy Benefits Metachromatic Leukodystrophy Science 2013, 341, 1233158 10.1126/science.1233158
398. Hacein-Bey Abina, S.; Gaspar, H.; Blondeau, J. et al. Outcomes Following Gene Therapy in Patients with Severe Wiskott-Aldrich Syndrome JAMA 2015, 313 (15) 1550-1563 10.1001/jama.2015.3253
399. Doudna, J. A.; Charpentier, E. Genome Editing. The New Frontier of Genome Engineering with CRISPR-Cas9 Science 2014, 346, 1258096 10.1126/science.1258096